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I Abbreviations 
dH2O deionized water 
[Ca2+]i  intracellular Ca2+ concentration 
APS ammonium persulfate 
BCAP  B cell adaptor for PI3K 
BCR  B cell antigen receptor 
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Btk Bruton’s tyrosine kinase 
Ca2+  Calcium ion  
CRAC  Ca2+ release activated Ca2+ channel 
DMEM  Dulbecco’s modified Eagle medium 
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dNTP  2’-deoxynucleoside-5’-trisphosphate 
Dok downstream of kinase 
DTT  1,4-dithiothreitol 
ECL  enhanced chemical luminescence 
EDTA  ethylenediamine tetraacetic acid 
EGTA ethylene-glycol-bis(2-aminoethyl ether)-N,N,N’,N’- 
tetraacetic acid 
ER  endoplasmic reticulum 
ERK  extracellular signal-regulated kinase 
F(ab')2 bivalent antigen-binding fragment 
FACS  fluorescence-activated cell sorter 
FCS fetal calf serum 
GEF  guanine-nucleotide exchange factor 
Grb2 growth factor receptor-bound protein 2 
HPK1  hematopoietic progenitor kinase 1 
HRPO  horseradish peroxidase 
Ig immunoglobulin 
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methylphenoxy]ethoxy]phenyl]-, (acetyloxy)methyl ester 
IP  immunoprecipitation 
IP3 inositol-1,4,5-trisphosphate 
JNK  c-Jun N-terminal kinase 
LAT linker for activation of T cells 
LB lysogeny broth 
Lyn  lck/yes-related novel PTK 
NCBI National Center for Biotechnology information 
NFAT  nuclear factor of activated T cells 
NF-κB  nuclear factor for κ gene in B lymphocytes 
NTAL non-T cell activation linker 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCR polymerase chain reaction 
PH  pleckstrin homology 
PI(3,4)P2 phosphatidylinositol 3,4-bisphosphate 
PI(3,4,5)P3  phosphatidylinositol 3,4,5-trisphosphate 
PI(4,5)P2  phosphatidylinositol 4,5-bisphosphate 
PI3K phosphatidylinositol 3’-kinase 
PLC-γ1/2  phospholipase C-γ1/2 
PTB  phosphotyrosine binding 
PTK protein tyrosine kinase 
pTyr phosphotyrosine 
Ras  abbreviation originated from rat sarcoma 
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RPMI  Roswell Park Memorial Institute 
RTK receptor tyrosine kinase 
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kDa 
SOCE store-operated Ca2+ entry 
SOS  son of sevenles 
src Rous sarcoma oncogene 
STIM stromal interaction molecule  
Syk Spleen tyrosine kinase 
TBS  Tris-buffered saline 
Tris  Tris-(hydroxymethyl)-aminomethane 
VSV-G  vesicular stomatitis virus glycoprotein 
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Alanine Ala A 
Cysteine Cys C 
Aspartic Acid Asp D 
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Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Lysine Lys K 
Leucine Leu L 
Methionine Met M 
Asparagine Asn N 
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Serine Ser S 
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1 Summary 
Signals emanating from the B cell antigen receptor (BCR) regulate both the activation 
of pathogen-specific B lymphocytes as well as removal of self-reactive B lymphocytes. 
The outcome of BCR stimulation can range from induction of apoptosis to proliferation. 
Inappropriate signals can therefore lead to an imbalance between humoral immunity and 
self tolerance. Consequently, B lymphocyte activation depends on a complex interplay 
between positive and negative signaling elements. The rise of the cytosolic Ca2+ 
concentration is a central step in B lymphocyte activation. The temporal shape of the 
Ca2+ signal contributes to the differential activation of transcription factors, which then 
affects cell fate decisions.  
The adaptor protein Grb2 has previously been shown to inhibit BCR-induced Ca2+ 
mobilization. During my work Björn Stork in our lab identified Dok-3 to be another 
adaptor protein inhibiting Ca2+ mobilization in B cells. In this study I investigated the 
molecular mechanisms of the inhibitory function of the two adaptor proteins. 
Using DT40 B cells that were rendered deficient for Grb2 or Dok-3 expression it could 
be shown that both proteins inhibit activation of the Ca2+ mobilizing enzyme PLC-γ2 by 
Btk. This was evident from enhanced BCR-induced phosphorylation of PLC-γ2 at a 
specific Btk phosphorylation site in the absence of Dok-3 or Grb2. This finding was 
supported by enhanced IP3 production and a stronger degree of depletion of Ca2+ from 
the ER stores in response to BCR ligation. An impact of the two adaptor proteins on the 
activation of plasma membrane Ca2+ channels could be excluded by uncoupling the 
release of Ca2+ from the ER from Ca2+ influx across the membrane. Although both 
proteins seem to form a ternary complex with the inhibitory lipid phosphatase SHIP, 
this interaction could be shown not to be essential for Dok-3 function. Rather, SHIP 
seems to promote Dok-3 phosphorylation. FcγRIIb coligation to the BCR strongly 
activates SHIP and this could be shown to also enhance Dok-3 phosphorylation.  
Together, this study reveals insights in the molecular mechanism by which the cytosolic 
adaptor proteins Dok-3 and Grb2 regulate BCR signaling and identifies FcγRIIb as an 
upstream regulator.  
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1.1 Zusammenfassung 
Signale des B Zell Antigenrezeptors (BZR) regeln sowohl die Aktivierung 
pathogenspezifischer B Lymphozyten als auch die Eliminierung selbstreaktiver B 
Lymphozyten. Das Ergebnis der BZA Stimulation kann von Apoptose bis zu 
Proliferation der B Lymphozyten reichen. Unpassende Signale können deshalb zu einer 
Unausgewogenheit zwischen der humoralen Immunität und Selbsttoleranz führen. 
Folglich hängt die B Lymphozyten-Aktivierung von einem komplizierten Wechselspiel 
zwischen positiven und negativen Signalelementen ab. Der Anstieg der zytosolischen 
Kalziumionen (Ca2+) Konzentration ist ein zentraler Schritt in der B Lymphozyten-
Aktivierung. Die zeitliche Form des Ca2+ Signals trägt zur differentiellen Aktivierung 
von Transkriptionsfaktoren bei, welche dann das Schicksal der Zelle beeinflussen. Das 
Adapterprotein Grb2 hemmt BZR-vermittelte Ca2+-Mobilisierung. Während meiner 
Arbeit identifizierte Björn Stork in unserem Labor Dok-3 als ein weiteres 
Adapterprotein, das Ca2+ Mobilisierung in B Zellen hemmt.  
In dieser Arbeit habe ich die molekularen Mechanismen der hemmenden Funktion der 
zwei Adapterproteine. untersucht. Dafür wurden DT40 B-Zellen verwendet, deren Gene 
für Grb2 oder Dok-3 inaktiviert worden sind. Damit konnte gezeigt werden, dass beide 
Proteine die Aktivierung des Ca2+-mobilisierenden Enzyms PLC-γ2 durch  Btk 
hemmen. Dies zeigte sich durch eine erhöhte BZA-vermittelte Phosphorylierung von 
PLC-γ2 an einer spezifischen Btk-Phosphorylierungsstelle in der Abwesenheit von 
Dok-3 oder Grb2. Dieser Befund wurde durch erhöhte IP3-Produktion und einen 
stärkeren Grad der Entleerung der intrazellulären Ca2+-Speicher nach BZR-Stimulation 
unterstützt. Der beobachtete Einfluss der zwei Adapterproteine auf der Aktivierung von 
Ca2+-Kanälen in der Plasmamembran verschwindet, wenn die Speicher künstlich 
entleert sind. Daher scheinen die beiden Adapterproteine ausschließlich die Ca2+ 
Mobilisierung aus intrazellulären Speichern zu beeinflussen. Obwohl beide Proteine 
einen ternären Komplex mit dem hemmenden Lipidphosphatase SHIP bilden, scheint 
diese Wechselwirkung für die Dok-3-Funktion nicht notwendig zu sein. Eher scheint 
SHIP die Dok-3-Phosphorylierung zu fördern. Koquervernetzung von FcγRIIb mit dem 
BZR führt zu starker SHIP-Aktivierung und ich konnte zeigen, dass dies auch zu 
verstärkter Dok-3-Phosphorylierung führt. Diese Studie zeigt Einblicke in die 
molekularen Mechanismen, durch die die zytosolischen Adapterproteine Dok-3 und 
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Grb2 BZR-Signale regeln und identifiziert FcγRIIb als Regulator des Dok-3-Grb2-
Moduls. 
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2 Introduction 
2.1 The Immune System 
The vertebrate immune system is comprised of a diverse set of leukocytes emanating 
from pluripotent hematopoietic stem cells that secure the survival of the organism by 
detecting and eliminating pathogens. 
The immune system can be divided into two interconnected subsystems: The innate 
immune system recognizes and attacks pathogens based on common pathogen-
associated molecular patterns (PAMPs), like bacterial cell wall constituents. 
Recognition of the pathogen by components of the innate immune system also leads to 
the activation of the adaptive immune system, which produces cells that specifically 
recognize the invading pathogen. Adaptive immunity can be divided into humoral and 
cellular immunity. Humoral immunity is mediated by antibodies and is directed against 
extracellular pathogens. Antibodies are secreted proteins that specifically bind antigens 
of the pathogen and binding leads to neutralization or targeting of the pathogen for 
elimination by various effector mechanisms. Cellular immunity is mediated by T 
lymphocytes and is directed against intracellular pathogens, which are inaccessible to 
antibodies. T lymphocytes destroy intracellular pathogens by either activating 
macrophages to kill the pathogen or by killing infected cells to eliminate reservoirs of 
infection.  
The humoral immune response is based on a large repertoire of randomly rearranged 
antigen receptor genes. These genes are expressed in lymphocytes, each lymphocyte 
carrying only one rearranged gene and thus only one antigen receptor. Binding of these 
receptors to their cognate antigen leads to the production of large amounts of the 
receptor in soluble form, which are then called antibodies. This system, which has 
essentially been postulated by Paul Ehrlich in his “side chain theory” (Ehrlich, 1900), 
has evolved in parallel in jawless fish using modules of leucine-rich repeats (Alder et 
al., 2008; Pancer et al., 2004) and in higher vertebrates using immunoglobulin gene 
segments (Cooper and Alder, 2006).  
 2  Introduction 2 
2.2 Antibody production by B lymphocytes in higher vertebrates 
The antigen receptors of the higher vertebrate humoral immune system are expressed as 
membrane-bound immunoglobulins at the surface of B lymphocytes and together with 
two signaling subunits, Igα and Igβ, comprise the B cell antigen receptor (BCR). 
Binding of antigen to its cognate BCR leads to internalization of the receptor and 
transport of antigen to endolysosomes, where the antigen is processed and loaded on 
MHC class II molecules. T helper cells, recognizing the antigen loaded MHC II, then 
activate the B cell and induce the germinal center reaction.  
Unlike T cells, B cells respond to unprocessed extracellular antigens. Thus, they face 
the problem that these antigens are extremely diverse; they may be soluble or 
particulate, contain a single or multiple epitopes, may or may not be opsonizable by 
molecules of the innate immune system (complement, pattern recognition molecules or 
natural antibodies) and may be available in very low to very high concentrations. To 
challenge these problems, the immune system seems to have evolved many different 
ways to activate B cell subsets. A recent report shows that soluble antigen can passively 
diffuse into B cell follicles of lymph nodes where it encounters B cells (Pape et al., 
2007). Another report for the first time shows, that B cells can be activated by dendritic 
cells (DCs) presenting native antigen on their surface (Qi et al., 2006). It has been noted 
previously that B cells are activated much more efficiently by antigen displayed on 
cellular surfaces. Groundbreaking work in the laboratory of Facundo Batista showed 
that B cells sense the affinity to membrane-bound antigens by spreading on the 
displaying surface forming a immunological synapses similar to T cells (Batista et al., 
2001; Fleire et al., 2006). Supporting the importance of membrane-bound native 
antigens, a very recent report shows that macrophages of the lymph node subcapsular 
sinus facilitate activation of B cells by collecting particulate antigen from the lymph and 
transporting it in native form into the B cell follicle (Carrasco and Batista, 2007; Junt et 
al., 2007). In a similar manner marginal zone B cells appear to transport opsonized 
antigen from the marginal zones of the spleen to the follicles (Cinamon et al., 2008). 
These studies indicate how B cells could also efficiently respond to antigen with only 
one epitope or how antigen can be concentrated for B cell activation.  
 2  Introduction 3 
Besides activation of mature B cells, the signal emanating from the BCR plays a pivotal 
role in the development of B cells. Signaling by the pre-BCR is required for the 
transition of pro B cells to the pre B cell stage and signaling by the nascent BCR is 
required for transition of pre B cells to the immature B cell stage. Further, BCR signals 
are required for induction of tolerance by deletion of autoreactive B cells, B cell 
selection in the germinal centers and reactivation of memory B cells. (King and 
Monroe, 2000; Wang and Clark, 2003)) 
2.3 Regulation of cytosolic Ca2+ concentration in B cells 
Ca2+ ions act as second messenger downstream of various receptors. The intracellular 
Ca2+ concentration in eukaryotic cells has to be kept very low, since many 
phosphorylated compounds form insoluble precipitates with Ca2+. This and other facts 
make the Ca2+ ion an ideal second messenger in intracellular signal transduction. Ca2+ 
can bind to various proteins and induce a conformational change upon a transient rise in 
cytosolic Ca2+ concentration (Williams, 1998).    
In B cells, the rise in cytosolic Ca2+ concentration in response to BCR ligation by 
antigen is a central step in the activation of several signal-transduction pathways, 
leading to activation of key transcriptions factors like nuclear factor of activated T cells 
(NFAT) and NF-κB (Engelke et al., 2007). 
BCR ligation triggers elevation of intracellular Ca2+ concentrations through activation 
of phospholipase C-γ2 (PLC-γ2), which in turn hydrolyzes membrane phospholipids to 
yield soluble inositol 1,4,5-trisphosphate (IP3). IP3 receptors are ligand gated Ca2+ 
channels located in the membrane of the endoplasmic reticulum (ER), which is the main 
storage for intracellular Ca2+. Hence, IP3 production causes release of Ca2+ from the ER 
to the cytosol, which results in a first rise in intracellular Ca2+ concentration. Since the 
amount of Ca2+ in the ER is limited, this Ca2+ release is transient. The IP3-driven Ca2+ 
release is followed by entry of Ca2+ ions from the extracellular space through calcium-
release-activated calcium (CRAC) channels, which contain ORAI-family  proteins 
(Feske et al., 2006; Yeromin et al., 2006). This process is induced by depletion of the 
ER Ca2+ stores and is thus referred to as store-operated Ca2+ entry (SOCE). The reduced 
Ca2+ concentration of the ER is thought to induce a conformational change in stromal 
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interaction molecule (STIM) proteins, which are transmembrane proteins of the ER 
membrane. This leads to STIM binding to CRAC channels and activation of the latter 
(Wu et al., 2006; Zhang et al., 2005). The phase of Ca2+ entry across the plasma 
membrane can last longer than the first, since the amount of Ca2+ in the extracellular 
space is not as limited as the intracellular stores. Importantly, SOCE is only activated, 
when a certain threshold of IP3 accumulation and store depletion is reached (Parekh et 
al., 1997). This has the effect of allowing small differences in the level or duration of 
PLC activation to lead to very large differences in the shape and especially in the 
duration of the Ca2+ signal. The shape of the Ca2+ signal leads to activation of distinct 
transcription factors and is thought to contribute to cell fate determination like 
proliferation, anergy or apoptosis (Dolmetsch et al., 1997). 
Independent of the amount of Ca2+ released from the ER, the cytosolic Ca2+ 
concentration can be regulated by several other mechanisms. The driving force of Ca2+ 
across the plasma membrane is strongly dependent on the plasma membrane potential. 
BCR ligation has indeed been shown to induce membrane depolarization in a B cell line 
(Hashimoto et al., 2001). Further, Ca2+ can be actively transported out of the cytosol 
into the extracellular space or back into the ER by plasma membrane Ca2+ ATPases 
(PMCAs) or sarco/endoplasmic reticulum Ca2+ ATPases (SERCAs), respectively. The 
negative co-receptor CD22 has been shown to activate PMCAs to limit rise in 
intracellular Ca2+ concentration (Chen et al., 2004). Furthermore, mitochondria have 
been shown to buffer cytosolic Ca2+ by passive uptake of Ca2+ and  extrusion through 
unknown Na+ or H+- gradient-driven active transporters (Chen et al., 2004; Jacobson 
and Duchen, 2004).  
2.4 Activation of PLC-γ2 downstream of the BCR 
Activation of PLC-γ2 requires recruitment of PLC-γ2 to the inner leaflet of the plasma 
membrane, phosphorylation by Bruton´s tyrosine kinase (Btk) and availability of its 
substrate phosphatidyl-inositol-4,5-phosphate (PI(4,5)P2). BCR crosslinking induces 
activation of tyrosine kinases of the Src and Syk family, which leads to phosphorylation 
and membrane recruitment of the central adaptor protein SLP-65 (Chiu et al., 2002; Fu 
et al., 1998; Wienands et al., 1998). Phosphorylated SLP-65 then recruits PLC-γ2 and 
Btk to the plasma membrane and into a ternary complex, called Ca2+ initiation complex 
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(Chiu et al., 2002; Su et al., 1999). This enables phosphorylation of PLC-γ2 by Btk, 
which is essential for activation of its catalytic activity.  
In parallel the activation of phosphoinositide 3-kinase (PI3K) by pathways involving 
CD19 or B cell adaptor for PI3K (BCAP) leads to the production of phosphatidyl-
inositol-3,4,5-phosphate (PI(3,4,5)P3) from PI(4,5)P2, which is also the substrate for 
PLC-γ2 (Aiba et al., 2008). PI(3,4,5)P3 binds with high affinity to the pleckstrin-
homology (PH) domain of Btk, enhancing its recruitment to the membrane (Bolland et 
al., 1998). As Btk constitutively interacts with phosphatidylinositol-4-phosphate 5-
kinase (PIP5K), recruitment of Btk also brings PIP5K to the membrane and into the 
same complex (Carpenter, 2004; Saito et al., 2003). PIP5K promotes the conversion of 
PI(4)P to PI(4,5)P2, replenishing the substrate of  PI3K and PLC-γ2. In this way, PI3K 
and Btk are part of a forward feedback loop (see Figure 1). 
2.5 Regulation of PLC-γ2 activation by positive and negative co-
receptors 
The exceptional role of the above forward feedback loop initiated by PI3K on the 
outcome of BCR signaling is shown by similar B cell phenotype in mice deficient for 
Btk, SLP-65, PLC-γ2 and PI3K (Scharenberg et al., 2007). Further, this forward 
feedback loop is target of several signal modulating co-receptors.  
Figure 1: Positive feedback loop in BCR signaling. See text for details 
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CD19 is one of the best studied co-receptors of the BCR and is part of a complex 
comprising also TAPA-1 and complement receptor 1 (CR1). Binding of the BCR to 
antigen, which is opsonized by complement, leads to co-ligation of the BCR with this 
complex. This brings CD19 close to the activated Src family kinases at the BCR, and 
leads to its phosphorylation and recruitment of the regulatory subunit of PI3K, namely 
p85. PI3K is in turn activated leading to the induction of the above mentioned feedback 
loop. Co-ligation of CD19 with the BCR thus lowers the threshold of antigen required 
to induce BCR signaling (Fearon and Carroll, 2000).  
Conversely, one of the best studied inhibitory co-receptors acts in a directly opposite 
way. Fcγ receptor IIb (FcγRIIb) is a low affinity receptor for the Fc part of IgG. It binds 
to immune complexes, a multivalent antigen opsonized with antibodies. When co-
ligated to the BCR, it inhibits the PI3K pathway. Recruitment of FcγRIIb to the BCR 
enables phosphorylation of its cytoplasmic immunoreceptor tyrosine-based inhibition 
motif (ITIM). This in turn recruits mainly the SH2 domain-containing inositol 5-
phosphatase (SHIP), which hydrolyses the product of PI3K, namely PI(3,4,5)P3, at the 
5´position to PI(3,4)P2. Note that PI(3,4)P2 is distinct from the PI3K and PLCγ2 
substrate PI(4,5)P2. Degradation of PI(3,4,5)P3 blocks PH domain-mediated Btk 
recruitment to the membrane and thus replenishment of PI(4,5)P2 from Btk-associated 
PIP5K (see Figure 1). Thus, PLC-γ2 signaling is drastically reduced due to limitation of 
its substrate, and block of Btk recruitment by PI(3,4,5)P3 (Nimmerjahn and Ravetch, 
2006). 
FcγRIIb has been shown to be essential for establishing peripheral tolerance (Tarasenko 
et al., 2007). Mice rendered deficient for FcγRIIb expression spontaneously develop a 
disease similar to systemic lupus erythematosus (SLE), which is characterized by the 
production of self antigen recognizing antibodies (Bolland and Ravetch, 2000; Takai et 
al., 1996). Since the autoimmune phenotype is strain dependent, other epistatic 
modifiers seem to be involved in disease susceptibility and severity (Bolland et al., 
2002). Also in humans mutations in the gene encoding FcγRIIb have been linked to 
susceptibility to SLE. A polymorphism in the human FcγRIIb promoter that reduces its 
expression and a mutation in the transmembrane domain of the receptor that blocks its 
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signaling capability have been described (Blank et al., 2005; Chen et al., 2006; Chu et 
al., 2004; Kono et al., 2005) 
2.6 Role of Dok-3 and Grb2 in BCR signaling 
Adaptor proteins are devoid of  catalytic activity and signal by assembling signaling 
complexes, relocating enzymatic entities to subcellular locations or altering enzyme 
activities (Pawson, 2007; Wienands, 2000). Previously, two adaptor proteins have been 
shown to inhibit Ca2+ mobilization in response to BCR stimulation, namely Grb2 
(growth factor receptor-bound protein 2) and Dok-3 (downstream of kinase-3). Grb2 is 
composed of a central SH2 domain flanked on either side by one SH3 domain (Figure 
2) (Lowenstein et al., 1992). It is expressed in all cell types and throughout the B cell 
lineage. B cells rendered deficient for Grb2 showed enhanced Ca2+ mobilization in 
response to BCR stimulation, depending on the central SH2 and the C-terminal SH3 
domain (Stork et al., 2004). The role of Grb2 in signaling downstream of receptor 
tyrosine kinases (RTKs) is well established. Both SH3 domains were demonstrated to 
bind the guanine nucleotide exchange factor (GEF) son of sevenless (SOS) (Buday and 
Downward, 1993). Binding of the central SH2 domain of Grb2 to activated receptors 
can thus recruit SOS to the membrane to activate the Ras/MAPK pathway (Egan et al., 
1993). Downstream of the BCR, activation of the Ras/MAPK pathway is independent 
of Grb2, though. In this scenario, Ras is activated by RasGRPs (Ras guanine nucleotide 
release protein) (Oh-hora et al., 2003). The mechanism of the negative regulatory role 
of Grb2 on Ca2+ signaling remains elusive, but during this thesis Björn Stork found that 
Grb2 associates via its SH2 domain with Dok-3 after BCR stimulation. As Dok-3 is also 
Figure 2 (A) Structural elements and known binding partners of Dok-3. Adapted 
from (Campbell, 2007)  
(B) Domain structure of Grb2 
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an adaptor protein, Grb2 and Dok-3 probably associate with another protein that is 
involved in signal transduction. Grb2 has been shown to interact in vivo or in vitro with 
roughly 190 proteins (Human Protein Reference Database). The mode of interaction, 
direct vs. indirect and the domains involved are unclear for most of them. Of the 
described interaction partners many have been described to be involved in BCR 
signaling, e.g. Dok-3, Vav, SLP-65, p85, HPK1, Cbl, CIN85, SHC, NTAL/LAT, CD19 
and SHIP (Brooks et al., 2000; Grabbe and Wienands, 2006; Harmer and DeFranco, 
1999; Honma et al., 2006; Huang et al., 2000; Johmura et al., 2003; Kavanaugh et al., 
1996; Kirsch et al., 1999; Oehrl et al., 1998; Stork, 2006; Weinger et al., 2008; 
Wienands et al., 1998; Ye and Baltimore, 1994)  
The family of Dok proteins comprises 7 members, which are cytosolic adaptor proteins. 
Dok-1 (alternatively called p62Dok), Dok-2 (alternatively called DokR) and Dok-3 
(alternatively called DokL) are predominantly expressed in cells of the hematopoietic 
lineage. They have a similar domain structure of an N-terminal PH domain followed by 
a phosphotyrosine-binding (PTB) domain and several tyrosine-based signaling motifs 
(see Figure 2 A). Dok-3 is expressed in B cells and myeloid cells. Upon BCR 
stimulation, it is tyrosine-phosphorylated and associates with SHIP, Grb2 and CSK 
(Lemay et al., 2000; Stork, 2006). Studies using overexpression of wild-type or a 
dominant negative mutant of Dok-3 in a B cell line suggested a selective role for the 
inhibition of NFAT and JNK activation downstream of the BCR, which was dependent 
on interaction with SH2 domain-containing 5`-inositol phosphatase (SHIP) (Robson et 
al., 2004). Ca2+ mobilization was not affected, though, which was surprising due to the 
well documented role of SHIP in Ca2+ inhibition. However, during this study, Björn 
Stork showed that DT40 B cells rendered deficient for Dok-3 show drastically enhanced 
Ca2+ mobilization in response to BCR stimulation. Grb2 seems to be involved in this 
inhibition as it is required for efficient phosphorylation of Dok-3. Together, the adaptor 
proteins Grb2 and Dok-3 seem to act as inhibitory signaling elements downstream of 
the BCR. Aim of this study was to elucidate the molecular mechanisms of the inhibition 
and to identify the catalytic entity regulated.   
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3 Aims of Work: 
This thesis addressed the question of how the small adaptor protein Grb2 is involved in 
signaling downstream of the BCR. It has previously been shown that Grb2 inhibits 
BCR-induced Ca2+ mobilization, especially Ca2+ influx from the extracellular space 
(Stork, 2004). The molecular mechanism of this phenomenon was unknown. During my 
work, Björn Stork in our laboratory found Dok-3 to interact with Grb2 in response to 
BCR ligation. He could further show, that Dok-3-deficient B cells showed a similar 
Ca2+ phenotype and thus postulated Dok-3 and Grb2 to constitute one signaling module 
together.  
DT40 B cells that were rendered deficient for Grb2 and Dok-3 were used to: 
1. characterize the impact of Grb2 and Dok-3 on the two phases of BCR-induced 
Ca2+ mobilization. 
2. identify the catalytic entity that is regulated by Grb2 and Dok-3. 
3. compare the mode of action of Grb2 and Dok-3 to test the hypothesis that they 
constitute a signaling module together.  
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4 Materials and Methods 
4.1 Materials 
All chemicals and biologically reactive reagents were purchased from Roth, Sigma-
Aldrich, Merck, Invitrogen (Gibco; Molecular Probes), Becton Dickinson, or GE 
Healthcare. All chemicals were purchased in pA quality unless otherwise indicated. 
 
4.1.1 Antibodies 
 
Table 1: Primary antibodies (WB, Western blot; IP, immunoprecipitation) 
Antibody supplier/reference application 
mouse anti-Grb2 (3F2) Upstate WB 
rabbit anti-actin Sigma WB 
rabbit anti-PLC-γ2 (Q-20) Santa Cruz 
Biotechnolgy 
WB, IP 
mouse anti-phosphotyrosine 
(pTyr) (4G10) 
Upstate WB 
rat anti-HA* (3F10) Roche WB, IP 
rabbit anti-mouse Dok-3 (Lemay et al., 2000) WB 
goat anti-mouse Dok-3 (D-18) Santa Cruz 
Biotechnology 
IP 
rabbit anti-chicken Dok-3 Lösing, 2007 WB, IP 
mouse anti-chicken IgM (M4) 
hybridoma 
(Chen et al., 1982) 
(Riken Cell Bank 
1611) 
DT40 stimulation 
goat anti-chicken IgM FITC Bethyl Laboratories FACS analysis 
 
rabbit anti-SHC Becton Dickinson  WB, IP 
goat anti-Dok-1  Santa Cruz 
Biotechnolgy 
IP 
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rabbit anti-Dok-1 Santa Cruz 
Biotechnolgy 
WB 
mouse anti-SHIP (P1C1) Santa Cruz 
Biotechnolgy 
WB 
rabbit anti-phospho-SHIP(Y1020) Cell signaling 
technology 
WB 
rabbit anti-phospho-Akt(S473) Cell signaling 
technology 
WB 
rabbit anti-Akt Cell signaling 
technology 
WB 
rabbit anti-phospho-Lyn(Y507) Cell signaling 
technology 
WB 
rabbit anti-phospho-SRC(Y416) Cell signaling 
technology 
WB 
rabbit anti-phospho-PLC-γ2 (Y759) Cell signaling 
technology 
WB 
rabbit anti-Btk Santa Cruz 
Biotechnolgy 
WB 
rat anti-mouse CD16/CD32 (2.4G2) Becton Dickinson Fc receptor 
blocking 
F(ab')2 fragment goat anti-mouse IgM, 
µ-chain specific 
Jackson 
ImmunoResearch 
mouse B cell 
stimulation 
rabbit-anti-mouse IgM, µ-chain specific Jackson 
ImmunoResearch 
mouse B cell  
stimulation 
 
4.1.2 Enzymes 
Restriction endonucleases   New England Biolabs 
Calf Intestine Phosphatase (CIP)  New England Biolabs 
T4 DNA Ligase   New England Biolabs 
Taq DNA polymerase  New England Biolabs 
Pfu DNA polymerase   Promega 
Moloney murine leukemia virus 
reverse transcriptase (MMLV-RT)  MBI Fermentas 
Topoisomerase    Invitrogen 
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4.1.3 Vectors and cDNAs 
Table 2: Vectors 
Vector    supplier/source application 
pCR2.1 Topo Invitrogen T/A cloning  
pApuroII T. Kurosaki High expression of 
proteins  
pMSCVpuro 
 
BD Biosciences Clontech Expression of Dok-3, and 
Grb2 
pLNCX2 BD Biosciences Clontech Expression of SHIP 
cDNA 
pHCMV-VSV-G M. Jücker expression of VSV-G/ 
pseudo-typing of 
retroviruses 
 
 
Table 3: cDNAs 
cDNA    supplier/source expression vectors 
chicken dok-3 B. Stork pMSCVpuro 
chicken grb2 B. Stork pMSCVpuro 
mouse grb2 A. Grabbe pMSCVpuro 
mouse ship 
 
J. Frey pLNCX2 
chicken btk cloned from DT40 mRNA pMSCVpuro, pApuro 
human fcgr2b J. Frey pBEHpac18 
 
 
4.1.4 Oligonucleotides 
All oligonucleotides were synthesized by MWG-Biotech (Ebersberg) 
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Table 4: Oligonucleotides 
Primer    sequence application 
chicken Btk fw Xba  ctt cta gag ctg ggg tgg ccg aca cloning of chicken Btk 
cDNA 
chicken Btk rev HA 
XhoI 
gtc aag cgt agt ctg gga cgt cgt 
atg ggt acg gct ctt cgt ctg tga tg 
cloning of chicken Btk 
cDNA 
mouse SHIP Y917F 
fw 
atg atc aat cca aac ttc att ggt atg 
ggg c  
mutagenesis of SHIP 
cDNA 
mouse SHIP Y917F 
rev 
gcc cca tac caa tga agt ttg gat 
tga tca  
mutagenesis of SHIP cDNA
mouse SHIP 
Y1020F fw 
gaa gga act cac gga tcc aaa cag 
tgg gtt ctc aaa 
mutagenesis of SHIP 
cDNA  
mouse SHIP Y1020F 
rev  
ttt gag aac cca ctg ttt gga tcc gtg 
agt tcc ttc 
mutagenesis of SHIP cDNA 
mouse SHIP ΔIPase 
fw 
caa cag gga tga agt acc tgg tgc atg 
tgg tct g 
mutagenesis of SHIP cDNA 
mouse SHIP ΔIPase 
rev 
cag acc aca tgc acc agg tac ttc 
atc cct gtt g 
mutagenesis of SHIP cDNA 
mouse SHIP K675A 
fw 
cgt cct ggt gcg ccc gtc ctg gtg 
gtg cgc cgc ccg agt cct ctg gaa g 
mutagenesis of s SHIP hip 
cDNA 
mouse SHIP K675 rev ctt cca gag gac tcg ggc gca cca gga 
cgg gcg cac cag gac g 
mutagenesis of SHIP 
cDNA 
Y140-FSSW fwd  
 
gga gaa ctg cct ctt ctc ctc gtg 
gca gg 
mutagenesis of chicken 
Dok-3 cDNA 
Y140-FSSW rev  
 
cct gcc acg agg aga aga ggc agt 
tct cc 
mutagenesis of chicken 
Dok-3 cDNA 
R197A fwd 
 
gcc cta ccc gtt cct cgc caa att 
cgg cca aga tc 
 
mutagenesis of chicken 
Dok-3 cDNA 
R197A rev 
 
gat ctt ggc cga att tgg cga gga 
acg ggt agg gc 
 
mutagenesis of chicken 
Dok-3 cDNA 
Y307-FASI fwd 
 
ctg ccc cta tag tgt ttg cct cca tcg 
cac g 
 
mutagenesis of chicken 
Dok-3 cDNA 
Y307-FASI rev 
 
cgt gcg atg gag gca aac act ata 
ggg gca g 
 
mutagenesis of chicken 
Dok-3 cDNA 
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Y331-FENI fwd 
 
ctc ccc gag cat ctc ttt gag aac atc 
ttc acg 
 
mutagenesis of chicken 
Dok-3 cDNA 
Y331-FENI rev 
 
cgt gaa gat gtt ctc aaa gag atg 
ctc ggg gag 
 
mutagenesis of chicken 
Dok-3 cDNA 
4.1.5 Solutions, buffers, and media  
The compositions of all solutions and buffers used are listed in the sections in which the 
corresponding experimental procedures are described. All solutions and buffers are 
aqueous solutions and stored at room temperature unless otherwise indicated. If 
solutions, buffers, or media had to be autoclaved it is indicated. Autoclaving of liquids 
was carried out at 125 °C for 30 min. RPMI medium was purchased endotoxin free and 
filter sterilized (Invitrogen).  
The following common buffers were used:  
PBS   137 mM NaCl; 27 mM KCl; 43 mM Na2HPO4 x 7 H2O; 14 mM  
KH2PO4; pH ~ 7.3    
TBS   20 mM Tris/HCl pH 7,6; 137 mM NaCl 
TE buffer  10 mM Tris/HCl, pH 8.0; 1 mM EDTA, pH 8.0    
4.1.6 Bacteria strains  
Production of Plasmid DNA was achieved by transforming Top10F´ bacteria as 
described in the corresponding sections. 
Genotype of Top10F’: 
F'[lacIq Tn10(tetR)] mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 deoR nupG 
recA1 araD139 Δ(ara-leu)7697 galU galK rpsL(StrR) endA1 λ-  
4.1.7 Additional materials  
GeneRulerTM 1 kb DNA ladder    (MBI Fermentas)  
Prestained Protein Marker, Broad Range (6.5-175 kDa) (New England Biolabs)  
Protease Inhibitor Cocktail (P 2714)    (Sigma-Aldrich)  
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Tissue culture equipment (dishes, pipettes, tubes etc.) (Greiner, Sarstedt)  
Electroporation cuvettes (4 mm gap)  (Peqlab)  
Nitrocellulose filter Hybond ECLTM   (Amersham Biosciences)  
ECLTM Western blotting detection reagents   (Amersham Biosciences)  
4.1.8 Instruments  
Eppendorf Thermomixer comfort  
Eppendorf centrifuge 5417R  
pH meter inoLab® pH Level 1  
Eppendorf BioPhotometer  
Eppendorf Mastercycler personal and Eppendorf Mastercycler epgradient  
Gel Imager (Intas, Göttingen)  
Heraeus HERAcell 150 (cell culture incubators)  
INFORS Unitron (37 °C shaker)  
Heraeus Kelvitron®t (bacteria incubator)  
Centrifuges SORVALL® RC 3B Plus and SORVALL® RC 26 Plus  
T70/T77 semi-dry transfer unit (Hoefer)  
Chemi Lux Imager (Intas, Göttingen)  
HERAsafe (cell culture bench)  
Heraeus Multifuge 3 S-R  
BIO-RAD Gene Pulser & BIO-RAD Capacitance Extender  
FACSCalibur (Becton Dickinson)  
LSR II (Becton Dickinson)  
4.1.9  Software   
CellQuest; FlowJo (Treestar)  
CSX-1400M Camera Controller (Chemi Lux Imager)  
Gel documentation software GDS (Gel Imager)   
Adobe® Photoshop® CS2 (image editing)  
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pDRAW 3.1; (in silico DNA analysis)  
CorelDraw; MS Office   
Endnote 7 
4.2 Experimental Procedures 
4.2.1 Methods in Molecular Biology 
4.2.1.1 Digestion of DNA using restriction enzymes 
For the sequence-specific cleavage of DNA molecules the purified DNA was incubated 
with restriction endonucleases according to the manufacturer’s instructions. 
4.2.1.2 Agarose gel electrophoresis of nucleic acids 
Gels were prepared by dissolving 0.8-2% agarose (w/v) in TAE buffer. The agarose was 
melted in a microvave, ethidium bromide was added to a final concentration of 0.5 
μg/ml, and the solution was poured into a sealed gel casting platform. The DNA 
samples to be resolved were mixed with an appropiate volume of 6x DNA loading 
buffer. Additionally a DNA molecular weight standard was loaded (GeneRuler 1 kb 
DNA ladder, MBI Fermentas). The electrophoresis was performed in a gel chamber 
filled with TAE buffer at a voltage of 5 V/cm distance between electrodes. 
 
TAE-buffer.....................   40 mM Tris-acetate, 1 mM EDTA 
6x loading buffer............ 10 mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 60% 
glycerol 
 
4.2.1.3 Extraction of DNA from agarose 
Isolation of DNA fragments from agarose gels was achieved with Wizard SV Gel and 
PCR Clean-Up System (Promega) according to manufacturer’s instructions. 
DNA was eluted with 50µl of dH2O. 
4.2.1.4 Ethanol precipitation of DNA 
 DNA solutions were concentrated by ethanol precipitation by adding 1/10 volume 3 M 
NaOAc (pH5.2) followed by 2.5 volumes of ice-cold 100 % ethanol, and the samples 
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were then placed at -20 °C in a prechilled metal block for 5-10min. The samples were 
centrifuged at 16,000 xg at 4°C for 10 min. The supernatant was discarded and the DNA 
pellet was washed with 70% ethanol, centrifuged as before and the DNA pellet was air-
dried. The dry pellet was dissolved in an appropriate volume of dH2O or TE buffer, pH 
8.0. 
4.2.1.5 Photometric determination of DNA and RNA concentrations 
DNA and RNA concentrations were determined using a BioPhotometer (Eppendorf) 
according to manufacturer’s instructions. The DNA and RNA concentrations are 
calculated by the following formulas: 
1 A260 Unit of dsDNA ≈ 50 μg/mL H2O 
1 A260 Unit of ssRNA ≈ 40 μg/mL H2O 
The purity of DNA or RNA can be estimated by the following values: 
pure DNA: A260/A280 ≥ 1.8 
pure RNA: A260/A280 ≥ 2.0 
Low purity DNA (Minipreps) concentrations were further estimated by agarose gel 
electrophoresis.  
4.2.1.6 Dephosphorylation of vector DNA 
Prior to ligation, the vector DNA was dephosphorylated at the 5`-end with calf intestine 
phosphatase (CIP) (NEB). 0.5 μL CIP (1U/μL) was directly added to each 20 μL of 
restriction digest and incubated at 37°C for up to 1 h. After gel electrophoresis the 
dephosphorylated vector DNA was extracted from agarose (see 4.2.1.3). 
4.2.1.7 Ligation of DNA fragments 
For the ligation of linearized vectors and DNA fragments encoding proteins (inserts) T4 
DNA ligase was used (NEB) according to manufacturer´s instructions. This enzyme 
catalyzes the formation of phosphodiester bonds between adjacent 3`-OH and 5`-PO4 
ends in dsDNA. For ligations a molar ratio of 1/3 (vector/insert DNA) was chosen. 
Usually 20ng of vector was subjected to ligation in a 10µl reaction. In order to check the 
ability of vector DNA to religate, one sample was set up without the addition of insert 
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DNA. Ligation reactions were incubated at 16°C overnight, and used directly for the 
transformation of competent bacteria. 
 
4.2.1.8 Generation of transformation competent E. coli bacteria and transformation 
5 ml LB medium were inoculated with the E. coli strain and incubated at 37°C 
overnight with shaking (180 rpm). The next day 150 ml LB medium were inoculated 
with 900 μl overnight culture. The culture was grown until an OD600 value of 0.45-
0.55 was reached. The bacteria suspension was put on ice for 10 min and then harvested 
at 5,000 xg at 4°C for 10 min. The supernatant was removed and the bacteria were 
resuspended with 30 ml TFB I. After 10 min incubation on ice, the bacteria were 
centrifuged and resuspended in 6 ml ice-cold TFB II. 50 μl portions of this cell 
suspension were transferred to a 1.5 ml test tube and were flash frozen with liquid 
nitrogen. The competent bacteria were stored at -80°C until needed. 
 
LB medium  10 g tryptone; 5 g Yeast Extract; 10 g NaCl ad 1000 mL 
TFB I   50 mM MnCl2 · 4 H2O; 100 mM KCl; 10 mM CaCl2 · 2 H2O; 30 
mM KOAc, pH 6.0; 15 % (v/v) glycerol; adjust to pH 6.1 with 
HOAc; autoclaved; 4 °C storage 
TFB II   75 mM CaCl2 · 2 H2O; 10 mM KCl; 10 mM MOPS; 15 % (v/v)  
   glycerol; adjust to pH 7.0 with KOH; autoclaved; 4 °C storage 
 
Competent bacteria were thawed on ice. 10-50 ng of plasmid DNA or 5 μL of a ligation 
reaction were added to the bacteria and the suspension was mixed by gently flicking the 
tube. The transformation sample was incubated on ice for 15 min and then heat-shocked 
at 42°C for 60 s. The bacteria were  returned to ice for 2 min and then 800 μL LB 
medium were added, and incubated at 37°C for 45 min. Subsequently, the bacteria were 
harvested at 6000 xg for 2 min, taken up in 150 µl LB medium and spread onto LB 
plates containing an appropriate antibiotic and incubated at 37°C overnight. 
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4.2.1.9 Isolation of Plasmid-DNA 
For the analytical plasmid isolation (Miniprep) 5 ml LB medium supplemented with the 
appropriate antibiotic were inoculated with a single bacterial colony at 37°C in a shaker 
(180 rpm) overnight. The next day the plasmid DNA was isolated using the Wizard® 
Plus SV Minipreps Kit (Promega) according to manufacturer’s instructions. For the 
production of larger amounts of plasmid DNA (Midiprep), 100-150 ml LB medium 
supplemented with the appropriate antibiotic were inoculated and the culture was grown 
at 37°C in a shaker (200 rpm) overnight to a density of OD600 2-4. The preparation of 
plasmid DNA was carried out with the NucleoBond PC 100 (Macherey-Nagel) 
according to manufacturer’s instructions. 
4.2.1.10 Isolation of total RNA from eukaryotic cells 
Total RNA was isolated by using the RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. Disruption and homogenization of cell lysates was carried 
out using QIAshredder columns (Qiagen) according to manufacturer’s instructions. The 
isolated RNA was used directly for reverse transcription or stored at -80 °C. 
4.2.1.11 Polymerase chain reaction: 
The Polymerase chain reaction is a technique for the selective in vitro amplification of 
specific DNA fragments (Saiki et al., 1985; Mullis et al., 1986; Mullis and Faloona, 
1987). 
For amplification of chicken Btk cDNA and for introducing mutations, e.g. epitope tags, 
at the 5` or 3` end of a cDNA, PCR reactions were performed using the thermostable 
proofreading polymerase Pfu (Promega). Reactions were set up according to 
manufacturer’s instructions.  
4.2.1.12 Site directed mutagenesis: 
Site directed mutagenesis was performed according to a published protocol (Fisher and 
Pei, 1997). 
Briefly, two complementary synthetic oligonucleotides of 30-35 bases were utilized, 
containing the desired mutation in the middle. After a PCR reaction using Pfu DNA 
polymerase to amplify the complete plasmid the parental DNA is degraded by DpnI 
 4  Materials and Methods 20 
(this enzyme only digests methylated DNA). The reaction is transformed into Top10F´ 
competent bacteria and plasmids from individual clones are analyzed for carrying the 
desired mutation.  
4.2.1.13 Cloning of PCR products  
PCR products generated with Pfu polymerase were purified using Wizard SV PCR 
clean up Kit (Promega) and incubated with Taq polymerase (NEB) at 72°C for 10min to 
add 3`-A overhangs. The reaction was set up like a standard PCR reaction according to 
the manufacturer´s recommendations.  
Cloning of PCR products with 3’-A overhangs was carried out using the TOPO TA 
Cloning Kits from Invitrogen, using the pCR2.1-Topo vector. The ligation reactions 
were set up according to the manufacturer’s instructions.  
4.2.1.14 DNA sequence analysis 
Sequencing was performed by MWG Biotech (Ebersberg, Germany). 
 
4.2.2 Cell culture methods 
4.2.2.1 Cell lines 
DT40 (ATCC Number: CRL-2111) 
The chicken DT40 B cell line is derived from an avian leucosis virus (ALV)-induced 
bursal lymphoma (Baba and Humphries, 1984; BABA et al., 1985). The original 
lymphoma was induced by viral infection of a 1 day old chicken with Rous-associated 
virus 1 (RAV-1). DT40 cells express surface IgM and continue to undergo IgL gene 
conversion during in vitro cell culture (Buerstedde et al., 1990; Kim et al., 1990). The 
most unique feature of DT40 cells is the high ratio of targeted to random integration of 
exogenous DNA. Targeted integration occurs in frequencies similar to those of random 
integration (Buerstedde and Takeda, 1991).  
 
WEHI-231 (ATCC Number: CRL-2111) 
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WEHI-231 B cells derive from a mineral-oil induced tumor in (Balb/c x NZB) F1 mice. 
They express surface IgM. 
Bal17.TR 
Subclone of the IgM-containing Bal17 murine lymphoma, which has lost Grb2 
expression for unknown reasons (Harmer and DeFranco, 1999). 
4.2.2.2 Cell culture conditions 
All used cell lines were cultured in a 5% CO2 humidified atmosphere at 37°C. Wild-
type DT40 B lymphocytes and derivatives were cultured in RPMI1640 containing 10% 
FCS, 1% CS, 2 mM L-glutamine, 50 μM β-mercaptoethanol, 50 U/mL penicillin, and 
50 μg/mL streptomycin. Murine B cell lines Bal17.TR and WEHI-231 were cultured in 
RPMI1640 containing 10% FCS, 2 mM L-glutamine, 1 mM pyruvate, 50 μM β-
mercaptoethanol, 50 U/mL penicillin, and 50 μg/mL streptomycin. Plat-E cells were 
cultured in DMEM containing 10% FCS, 2 mM L-glutamine, 10 μg/mL blasticidin, 2.5 
μg/ml puromycin, 50 U/mL penicillin, and 50 μg/mL streptomycin. The adherent 
growing Plat-E cells were split using Trypsin/EDTA solution after rinsing 1x with PBS. 
4.2.2.3 Freezing and thawing of eukaryotic cells 
For freezing, 1x107 cells were harvested and resuspended in 1 ml of freezing medium 
(90% (v/v) FCS, 10% (v/v) DMSO). Vials were placed in a polystyrene box at -80°C 
for 24 h and then transfered to -150°C for long term storage.  
Cells were thawed rapidly at 37°C and immediately washed in 10ml of culture medium. 
Cells were transfered in fresh culture medium into a cell culture dish and cultured as 
described above. 
4.2.2.4 Transfection of DT40 lymphocytes by electroporation 
1 x107 cells were harvested, washed with PBS, and resupended in 0.7 ml PBS. Then 
25 μg of linearized DNA and the cell suspension were transferred to an electroporation 
cuvette (4 mm electrode gap, Peqlab Biotechnologie GmbH, Germany). After 10 min 
incubation on ice the cells were electroporated at 260 V and 960 μF . The electroporated 
cells were incubated on ice for 10 min and resuspended in DT40 medium. The cells 
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were cultured for 24 h and then resuspended in DT40 medium containing the 
appropriate selective antibiotic (see below). The cells were plated in two 96-well-dishes 
with 0.2 mL/well. After 7-10 days stable transfectants were visible and transferred to 
24-well-dishes for further analysis. 
Concentrations used: 
300 µg/ml Zeocin or 30µg/ml Bleocin  
50 µg/ml Blasticidin  
2 mg/ml G418  
1 µg/ml Puromycin  
4.2.2.5 Transfection of Plat-E cells with FuGENE6 for the production of recombinant 
viruses 
Plat-E cells were used as packaging cell line for the production of recombinant, 
replication incompetent retroviruses. These retroviruses were then used for the 
transduction of B lymphocytes. Plat-E cells were split 24 h prior to transfection to reach 
about 50-70% confluency at the time of transfection (6 cm dish).  
The following components were mixed in the given order: 
200μL RPMI w/o supplements 
7.5 μL FuGENE6® (Roche Diagnostics) (directly pipetted into liquid) 
1.9 μg retroviral expression vector (pMSCV or pLNCX2) 
0.7 μg phCMV-VSV-G (for pseudotyping retroviruses, if DT40 chicken cells were to be 
transduced) 
The components were mixed by tapping and left at RT for 30 min at RT. The Plat-E 
medium was aspirated from the dish and fresh DT40 medium was given onto the cells. 
The transfection mixture was added dropwise to the cells. After 48h incubation at 5% 
CO2 and 37°C, the cell supernatant containing the retroviruses was used for 
transduction. 
4.2.2.6 Transfection of lymphocytes by retroviral gene transfer 
The retroviral gene transfer technology introduces efficiently stable, heritable genetic 
material into the genome of any dividing cell type. The retroviral gene transfer 
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technology is based on the parallel design of packaging cell lines and retroviral 
expression vectors. Packaging cell lines package recombinant retroviral RNAs into 
infectious, replication-incompetent particles. In a packaging cell line, the viral gag, pol, 
and env genes are stably integrated into the genome. Transfection of the retroviral 
vector into a packaging cell line produces replication-incompetent viruses, with the viral 
genomic transcript containing the target gene and the selectable marker. The viral env 
gene expressed by the packaging cell line encodes the envelope protein. This protein 
determines the range of infectivity (tropism) of the packaged virus. 
4.2.2.7 Transfection of DT40 cells with recombinant retroviruses 
The retrovirus-containing supernatant of the transfected PlatE cells was sterile filtered 
using 0.45 µm pore size and applied to a new 6cm cell culture dish. 1x106 DT40 or 
Bal17.TR cell were suspended in 1.5ml of fresh medium and mixed with the retrovirus-
containing supernatant. Polybrene from a freshly prepared stock solution (3 mg/ml in 
dH2O) was added to a concentration of 3 µg/ml. Cells were incubated for 24h under 
standard cell culture conditions. To remove remaining retrovirus, the cells were 
centrifuged and resuspended in 5 ml of fresh medium. 24h later the appropriate 
selective antibiotic was added to the cells. 
All manipulations of pseudo-typed retroviruses were performed incompliance with the 
S2 standard and safety instructions. 
4.2.2.8 Ca2+ mobilization analysis 
The Ca2+ response in B lymphocytes after stimulation was determined by flow 
cytometry using the Ca2+-sensitive fluorophor Indo-1. The acetoxymethyl ester 
derivative Indo-1 (Indo-1-AM) is hydrophobic molecule that is capable of permeating 
cell membranes. Within the cell, the lipophilic blocking group is hydrolized by 
cytoplasmic esterases, resulting in a charged form which can permeate the plasma 
membrane far more slowly than its parent compound (“dye-trapping”). 
Indo-1 is a ratiometric dye, i.e. the emission shifts from about 475 nm (blue) without 
Ca2+ to about 400 nm (violet) when complexed with Ca2+. Excitation maximum is at 
about 350 nm. The use of the 400/475 emission ratio considerably reduces the effects of 
unequal dye loading, leakage of dye, photobleaching, and problems associated with 
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measuring Ca2+ in cells of unequal size/shape. For Ca2+ mobilization analysis, 2 x106 
cells were harvested at 300xg and 4°C for 5 min. The cell pellet was resuspended in 1ml 
of the corresponding cell culture medium and Indo-1-AM was added to 1 µM. Cells 
were incubated 30min at 30°C and the 10min at 37°C. The cells were subsequently 
washed 1x with Krebs-Ringer solution and resuspended in 1 ml of Krebs-Ringer 
solution. Cells were then kept at 25°C until measurement but at least 15 min. If the 
intracellular Ca2+ level was to be analyzed independent of Ca2+ influx across the plasma 
membrane, the cells were harvested and resuspended in Krebs-Ringer solution 
containing EGTA instead of Ca2+ just prior to the measurement. Kinetic analysis of 
emission of Indo-1 at 385-425 nm (violet) and 500-560 nm (blue) was performed with a 
LSRII flow cytometer (Becton Dickinson).After taking a 30 s baseline cells were 
removed from the instrument, stimulated with BCR crosslinking antibodies as indicated 
in each figure and put back to the instrument. Kinetic graphs in each figure represent the 
median of all cells analyzed in a given second. Each experiment was performed at least 
3 times. 
Krebs-Ringer solution  10 mM HEPES, pH 7.0; 140 mM NaCl; 4 mM         
KCl; 1 mM MgCl2; 10 mM glucose 
Ca2+-containing   + 1 mM CaCl2 
Ca2+-free/EGTA-containing  + 0.5 mM EGTA 
Indo-1-AM stock   1 mM in DMSO; store at -20 °C 
4.2.3 Biochemical Methods 
4.2.3.1 Stimulation of B lymphocytes via the BCR 
B cells were harvested and washed once with RPMI 1640 medium without supplements. 
The cells were resuspended in RPMI 1640 medium without supplements at a density of 
2-4 x107 cells/ml and incubated at 37°C for 10-25 min. For stimulation of B cells via 
BCR alone or BCR + FcγRIIb the following crosslinking antibodies were added in the 
given order: 
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DT40:  
BCR stimulation  2 µg/ml M4  
BCR + FcγRIIb crosslinking 15 µg/ml IgG rabbit anti-mouse IgM 
2 µg/ml M4 
BCR stimulation (when compared to 
FcγRIIb co-ligation) 
10 µg/ml F(ab)2 goat anti-mouse IgM  
2 µg/ml M4 
 
WEHI231 / Bal17.TR:  
BCR stimulation 10µg/ml F(ab)2 goat anti-mouse IgM  
BCR + FcγRIIb crosslinking 15µg/ml IgG rabbit anti-mouse IgM 
 
After addition of the crosslinking antibodies the samples were vortexed and incubated at 
37°C for the indicated time. Reactions were stopped by placing on ice. Cells were 
harvested at 1000xg for 1 min at 4°C and the cell pellet was lysed in 250µl lysis buffer 
per 1 x107 cells. After 10 min incubation on ice the insoluble debris was removed by 
centrifugation for 10min at maximum speed at 4°C. The supernatant containing soluble 
material (cleared cellular lysate (CCL)) was transferred to a fresh tube. The CCLs were 
either directly mixed with 1/3 of 4x SDS sample buffer or used for 
immunoprecipitations. 
lysis buffer   TBS; 1% NP40; 5 mM NaF; 1 mM Na3VO4; protease 
    inhibitor cocktail 
4x SDS sample buffer 250 mM Tris/HCl, pH 6.8; 200 mM DTT; 40% glycerol; 
8 % SDS; 0.05% bromophenol blue 
4.2.3.2 Affinity purification and imunoprecipitation 
Affinity purification of proteins from CCLs was performed with GST-fusion protein 
containing the PTB domain of chicken Dok-3 and a mutant version (R297A) (in 
cooperation with M. Lösing). A 2 ml aliquot of the GST fusion protein was thawed on 
ice and centrifuged at maximum speed and 4 °C for 10 min. Glutathione Sepharose 4B 
beads (Amersham Biosciences) were added to the supernatant and rotated at 4 °C for at 
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least 1 h (binding capacity ~10 mg recombinant GST/ml medium). The beads were 
washed three times with lysis buffer (4.2.3.1). 10-20 μl beads were added to the CCLs 
of 2 x107 cells and rotated at 4 °C for at least 1 h. Then the beads were washed three 
times with lysis buffer (see 4.2.3.3.). Subsequently 40 µl 2x SDS sample buffer were 
added and the samples were heated to 95°C for 5 min. Purified proteins were resolved 
by SDS-PAGE. 
For immunoprecipitations of proteins from CCLs, 0.5-2 μg of the corresponding 
antibodies were added to the lysates of 1-2 x107 cells and rotated at 4°C for at least 1 h. 
Then 15-20 μl Protein A/G Agarose beads (Santa Cruz or Pierce) were added and 
protein complexes were captured while rotating at 4°C for 1h. Subsequently, the steps 
as described for affinity purifications were followed. 
4.2.3.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Separation of proteins was carried out based principally on the method of one-
dimensional, discontinuous electrophoresis in sodium dodecyl sulphate (Laemmli, 
1970). The final acrylamide concentration was 8-12.5 % for separating gels, and 4.8% 
for stacking gels. Prestained Protein Marker (6.5-175 kDa, New England Biolabs) was 
used as standard. The electrophoretic separation was carried out at a constant current of 
10 mA for stacking gels and 25 mA for separating gels. Subsequently gels were 
subjected or western blot analysis: 
separating gel    375 mM Tris/HCl, pH 8.8; 8-12.5% acrylamide; 0.1% 
 SDS; 0.1% TEMED; 0.1% APS 
stacking gel   125 mM Tris/HCl, pH 6.8; 4.8% acrylamide; 0.1% 
SDS; 0.1 % TEMED; 0.1 % APS 
SDS running buffer  25 mM Tris; 192 mM glycine; 0.1% (w/v) SDS 
 
4.2.3.4 Western blotting 
Western blotting was performed with a semidry transfer unit (Hoefer) according to the 
manufacturer´s instructions. Briefly, a sheet of transfer buffer-soaked filter paper was 
put in place on the anode. The filter paper was followed by the equilibrated 
nitrocellulose membrane, the gel and finally another sheet of transfer buffer-saturated 
 4  Materials and Methods 27 
filter paper. Air bubbles were rolled out as each component was added to the stack. The 
cathode was placed atop of the transfer stack and a current of max. 0.8 mA/cm2 gel was 
applied for 1 h. After transfer the unit was disassembled and the membrane with 
transferred proteins was subjected to immunoprobing with primary and secondary 
horseradish-peroxidase (HRPO)-conjugated antibodies. The membrane was first 
incubated in blocking solution for 1 h at 4°C overnight on a rocking platform, and 
thereafter washed three times for 5 min with TBS-T. The membrane was incubated with 
the primary antibody in blocking solution at 4°C overnight on a rocking platform. The 
membrane was washed with TBS-T three times for 5 min. The HRPO-conjugated anti-
immunoglobulin antibody was diluted 1/10,000 in TBS-T, and the membrane was 
incubated with the secondary antibody at 4°C for 1 h on a rocking platform. The 
membrane was washed with TBS-T four times for 10 min with mild agitation. The 
immunoblot was visualized using the ECL detection system (Amersham Biosciences). 
Detection of specific proteins was carried out by exposure of the membrane to a digital 
imaging system (Chemi Lux Imager, Intas). 
Transfer buffer  39 mM glycine; 48 mM Tris; 0.0375% (w/v) SDS; 0.01%  
  (w/v) NaN3; 20% MeOH 
Blocking solution  5% (w/v) BSA in TBS-T 
TBS-T    0.1% (v/v) Tween-20 in TBS 
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5 Results 
5.1 Grb2 and Dok-3 inhibit Ca2+ release from the ER Ca2+ stores 
BCR-induced Ca2+ mobilization occurs in two phases. In the first phase, the binding of 
IP3 to its receptors in the ER membrane results in release of Ca2+ from ER stores. The 
depletion of the Ca2+ stores leads to the second phase of sustained influx of extracellular 
Ca2+ across the plasma membrane.  
Studies using B cells deficient for the cytoplasmic adaptor protein Grb2 have shown 
that it inhibits Ca2+ mobilization in response to BCR stimulation (Stork et al., 2004). 
During my work on the molecular mechanism of this observation, Björn Stork in our 
laboratory identified the adaptor protein Dok-3 as a Grb2 binding partner that also 
inhibits Ca2+ mobilization (Stork, 2006). To test, how both of these proteins inhibit the 
rise in cytosolic Ca2+ in response to BCR crosslinking, their impact on the two phases of 
Ca2+ mobilization were investigated. As shown in Figure 3A, DT40 cells rendered 
deficient for Dok-3 or Grb2 expression show an increased rise in cytosolic Ca2+ 
concentration in both phases, release of Ca2+ from the ER and Ca2+ influx across the 
plasma membrane (provided by B. Stork). To monitor the relative cytosolic Ca2+ 
concentration, cells were loaded with the fluorescent Ca2+ indicator INDO-1 and 
analyzed by flow cytometry. To discriminate between the two phases of Ca2+ 
mobilization cells were stimulated in the absence of extracellular Ca2+ to prevent Ca2+ 
entry. After the signal terminated, Ca2+ was restored to 1 mM to allow for Ca2+ entry.   
The rise in the concentration of cytosolic Ca2+ in response to BCR ligation is due to IP3-
mediated depletion of the ER Ca2+ stores which then leads to opening of CRAC 
channels of the plasma membrane. Yet, there are other mechanisms by which the 
cytosolic Ca2+ concentration can be altered, e.g., activated Ca2+ pumps or Ca2+ 
exchanger can extrude Ca2+ to the extracellular space and thus limit cytosolic Ca2+ rises. 
Blocking of Ca2+ extrusion would phenotypically also lead to increased Ca2+ 
concentrations in both phases of BCR-induced Ca2+ mobilization (Chen et al., 2004). 
 
 5  Results 29 
 
Figure 3: Dok-3 and Grb2 inhibit Ca2+ mobilization in B cells. 
(A,F) BCR-induced intra- and extracellular Ca2+ mobilization of the indicated DT40 cells was recorded 
by flow cytometry as described in detail in Materials and methods. Briefly, cells were loaded with Indo-1 
and release of intracellular Ca2+ was measured for 6 min in the presence of EGTA. Subsequently, 
extracellular Ca2+ was restored to 1mM in order to monitor Ca2+ entry across the plasma membrane. 
Lines represent wild-type DT40 (orange), dok-3−/− mutants (black), Dok-3-reconstituted dok-3−/− cells 
(gray), grb2−/− mutants (blue) and wild-type and dok-3−/− transfectants expressing the dominant-negative 
W193K version of Grb2 (brown and green, respectively). 
(B,C) Ca2+ remaining in the ER of indicated DT40 cells was determined by stimulating the cells in the 
presence of EGTA. Ca2+ remaining in the ER Ca2+ stores released after 6 min by addition of 1µM 
Thapsigargin (TG) 
(D,E) Ca2+ entry with completely depleted ER Ca2+ stores. Indicated DT40 cells were stimulated by 
addition of anti-IgM and Thapsigargin in the presence of EGTA. After 6 min extracellular Ca2+ was 
restored to 1mM in order to monitor Ca2+ entry across the plasma membrane. 
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To asses, whether both Grb2 and Dok-3 indeed inhibit the release of Ca2+ from the ER, 
the amount of Ca2+ remaining in the ER after the first phase of Ca2+ release was 
determined in DT40 cells deficient for either Grb2 or Dok-3. The cells were stimulated 
via the BCR in the absence of extracellular Ca2+ and after the signal terminated, Ca2+ 
remaining in the ER was released to the cytosol by addition of Thapsigargin. 
Thapsigargin is an inhibitor of the ER membrane Ca2+ pump SERCA, which pumps 
Ca2+ from the cytosol into the ER. Inhibition of SERCA leads to passive diffusion of 
Ca2+ from the ER into the cytosol, which can be monitored by flow cytometry. As 
shown in Figure 3 B & C, in cells deficient for Grb2 or Dok-3 significantly less Ca2+ 
remains in the ER after the BCR-induced Ca2+ signal terminated. This shows that cells 
deficient for Grb2 or Dok-3 release more Ca2+ from the ER in response to BCR 
stimulation, i.e. both adaptor proteins inhibit Ca2+ release from the ER. Thus, the strong 
Ca2+ entry across the plasma membrane, observed in both Dok-3 and Grb2 deficient 
cells, could merely be due to a stronger degree of depletion of the ER Ca2+ stores, which 
induces opening of channels in the plasma membrane. Grb2 and Dok-3 could, however, 
also influence Ca2+ entry by directly regulating CRAC channels. To test this, the Ca2+ 
influx across the plasma membrane was measured after BCR stimulation of the cells in 
the presence of Thapsigargin, which completely depletes the Ca2+ from the ER. In this 
experimental setup, the Ca2+ influx is uncoupled from BCR-mediated store depletion, 
since the stores are completely depleted for each cell line. As shown in Figure 3 D & E, 
both Grb2 and Dok-3-deficient cells show similar Ca2+ entry as compared to their 
reconstituted counterparts in this experimental setup. This supports the notion that both 
adaptor proteins selectively inhibit Ca2+ release from internal stores, which then 
consequently inhibits store-operated CRAC channel opening.  
As Björn Stork showed during my work, Grb2 binds to and is required for Dok-3 
phosphorylation in response to BCR ligation. Thus, it was feasible to propose Dok-3 
and Grb2 to constitute one signaling module together. To test this notion, a dominant-
negative Grb2 mutant was employed, which harbors an inactivated C-terminal SH3 
domain (W193K). As the C-terminal SH3 domain of Grb2 is essential for inhibition of 
Ca2+ mobilization in response to BCR stimulation (Stork et al., 2004), expression of 
Grb2 W193K in DT40 cells overwrites the inhibitory function of endogenous wild-type 
Grb2 and allows for stronger Ca2+ flux (Figure 3 F). In contrast, expression of the Grb2 
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W193K protein in Dok-3-deficient DT40 cells has no effect on the Ca2+ profile, 
indicating that Dok-3 expression is required for the inhibitory function of Grb2. This 
supports the notion that Dok-3 and Grb2 constitute a functional unit to attenuate BCR-
induced Ca2+ mobilization. 
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5.2 Grb2 and Dok-3 inhibit BCR-induced activation of PLC-γ2 
Figure 4: The Dok-3/Grb2 module attenuates PLC-γ2 activity. 
(A) Dok-3-deficient DT40 mutants (lanes 4–6) and reconstituted cells expressing HA-tagged wild-type 
Dok-3 (lanes 1–3) were left untreated (0) or stimulated through their BCRs for the indicated times (min). 
Lysates were subjected to anti-PLC-γ2 immunopurification and proteins obtained were analyzed by anti-
pTyr and anti-PLC-γ2 immunoblotting (upper and lower panels, respectively). 
(B) Parental DT40 cells (lanes 1–4), dok-3−/− mutants (lanes 5–8) and HA-Dok-3-reconstituted 
transfectants (lanes 9–12) were left untreated (0) or stimulated through their BCRs for the indicated times 
(min). Cleared cellular lysates (CCL) were subjected to immunoblot analysis with antibodies that 
specifically detect PLC-γ2 phosphorylation at the Btk-dependent phospho-acceptor site corresponding to 
Y759 in human PLC-γ2 (upper panel). Equal protein loading was confirmed by reprobing the membrane 
with anti-PLC-γ2 antibodies (lower panel). Relative molecular mass of marker protein is indicated in (A) 
and (B) on the left in kDa. 
(C) DT40 mutant cells deficient for either Dok-3 (left panel) or Grb2 (right panel) and the empty vector 
control transfectants (open and filled bars, respectively) were left untreated (0) or BCR-activated for 0.5 
or 3 min. IP3 levels in these cells (2x106 cells per sample) were measured using a competitive binding 
assay with radiolabelled IP3-binding proteins. Error bars represent s.e.m. of three independent 
experiments with double preparation. 
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The release of Ca2+ from the ER into the cytosol in response to BCR ligation is 
mediated by  IP3  produced by PLC-γ2, which is activated by membrane recruitment 
and subsequent phosphorylation by Btk in the linker region at tyrosines 753 and 759 
(Kim et al., 2004). To assess the activation of PLC-γ2, the phosphorylation status of 
PLC-γ2 in Dok-3-deficient cells was assessed by immunoprecipitation of PLC-γ2 and 
subsequent Western-blot analysis using an anti-phospho-tyrosine antibody. As shown in 
Figure 4A, overall tyrosine phosphorylation of PLC-γ2 is only slightly increased in 
Dok-3-deficient cells. To more specifically assess phosphorylation of tyrosines required 
for activation, a phospho-specific antibody, recognizing Y759 of human PLC-γ2 only in 
its phosphorylated form, was used. This analysis shows a drastic increase of 
phosphorylation of this motif in Dok-3-deficient cells (Figure 4B). The kinetic and 
extent of PLC-γ2 phosphorylation at this specific residue was substantially upregulated 
in dok3-/- cells (lanes 5-8) compared with wild-type parental cells (lanes 1-4) or Dok-3-
reconstituted transfectants (lanes 9-12). Since phosphorylation of this residue by Btk 
has been shown to activate PLC-γ2 catalytic activity (Kim et al., 2004), the product of 
PLC-γ2, namely IP3, was determined in Dok-3-deficient cells. Indeed, IP3 levels were 
strongly increased in BCR-stimulated dok3-/- cells compared to reconstituted 
transfectants (Figure 4C, left panel). The same was also true for grb2-/- cells (Figure 4C, 
right panel). The result that Grb2 inhibits IP3 production appeared to be in conflict with 
previously published data, showing no difference in global PLC-γ2 phosphorylation in 
response to BCR ligation in Grb2-deficient DT40 cells (Stork et al., 2004). The specific 
analysis of Y759 phosphorylation of PLC-γ2 did not succeed using these cells due to a 
low signal to noise ratio. To increase PLC-γ2 phosphorylation, Btk was overexpressed 
in Grb2-deficient cells, as phosphorylation by Btk is critical for activation of PLC-γ2 
(Kim et al., 2004; Takata and Kurosaki, 1996). Overexpression of Btk in grb2-/- cells 
increased BCR-induced PLC-γ2 phosphorylation (Figure 5A, compare lanes 4 and 8). 
Reconstitution of Grb2 expression reduces total PLC-γ2 phosphorylation in these Btk-
overexpressing cells (Figure 5A, compare lanes 6 and 8). This indicates that Grb2 
inhibits Btk-mediated PLC-γ2 phosphorylation, and that the effect is merely too small to 
be visible in wild-type cells. In Btk-overexpressing cells it was also possible to analyze 
specifically phosphorylation of PLC-γ2 at Y759. Similar to the total phosphorylation of 
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the enzyme, the phosphorylation of Y759 was drastically increased in Grb2-deficient 
cells, as compared to reconstituted counterparts (Figure 5B, lanes 8 and 6, respectively). 
Together, these data show that both Grb2 and Dok-3 inhibit Ca2+ flux in response to 
BCR ligation by inhibiting activation of PLC-γ2 by Btk. 
 
 
Figure 5: Grb2 inhibits Btk-mediated PLC-γ2 phosphorylation 
(A) Grb2-deficient DT40 cells, either untransfected (lanes 1–4) or overexpressing 
Btk (lanes5-8), were reconstituted with Grb2 or empty vector and were  left 
untreated (-) or stimulated through their BCRs for 3min (+). Lysates were 
subjected to anti-PLC-γ2 immunopurification and proteins obtained were analyzed 
by anti-pTyr and anti-PLC-γ2 immunoblotting (upper and lower panels, 
respectively). 
(B) Lysates  from A  were subjected to immunoblot analysis with antibodies that 
specifically detect PLC-γ2 phosphorylation at the Btk-dependent phospho-
acceptor site corresponding to Y759 in human PLC-γ2 (upper panel). Equal 
protein loading was confirmed by reprobing the membrane with anti-PLC-γ2 
antibodies (middle panel) and Btk expression was analyzed by anti-Btk 
immunoblotting (lower panel).  
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5.3 Dok-3 acts independently of SHIP and CSK 
The phenotype of Dok-3 and Grb2-deficient DT40 cells closely resembles the 
phenotype of SHIP-deficient DT40 cells, as SHIP also inhibits Btk-mediated PLC-γ2 
activation  (Bolland et al., 1998; Hashimoto et al., 1999). Further, Dok-3 and Grb2 have 
both been shown to bind to SHIP in BCR stimulated B cells (Harmer and DeFranco, 
1999; Robson et al., 2004). To elucidate, whether the interaction with this negative 
regulator is responsible for the inhibitory function of the Grb2/Dok-3 module, mutants 
of Dok-3 were generated. In Dok-3-deficient cells reconstituted with these mutants, the 
ability of these mutants to inhibit Ca2+ flux was compared to their ability to bind to 
SHIP (The generation and analysis of the transfectants was done in cooperation with 
Ingo Goldbeck, Björn Stork and Michael Engelke). As shown in Figure 6B, deletion of 
Figure 6: Only PH-domain and Grb2-binding site are required for Dok-3-mediated inhibition of 
Ca2+-flux.. (A) Schematic representation of expression constructs encoding HA-tagged versions of 
wild-type Dok-3, a PH domain deletion mutant (ΔPH) or mutants encompassing amino-acid 
exchanges depicted in single-letter code. (B) Expression vectors were introduced by retroviral 
transduction in dok-3−/− mutants and BCR-induced Ca2+ mobilization of the transfectants was 
measured by flow cytometry, as described in the legend to Figure 3. Wild-type DT40 cells and empty 
vector transfectants of dok-3−/− mutants served as control (see inlay for color code) 
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the N-terminal PH-domain abrogates inhibition of Ca2+ mobilization by Dok-3. The 
association of this mutant with SHIP is also abrogated, as determined by co-
immunoprecipitation experiments (Figure 7, lanes 5 and 6). This was shown to be due 
to impaired membrane recruitment of Dok-3 (Goldbeck, 2007). Inactivation of the PTB 
domain of Dok-3 by introducing an amino acid exchange (R197A) does not interfere 
with Dok-3-mediated inhibition of Ca2+ mobilization (Figure 6B). Strikingly, this 
mutant does not co-precipitate SHIP (Figure 7, lanes 7 and 8). This indicates that the 
interaction between Dok-3 and SHIP is dispensable for Dok-3-mediated inhibition of 
Ca2+ flux in response to BCR ligation.  
There are three putative tyrosine phosphorylation sites in Dok-3. Y331 is essential for 
binding to Grb2, phosphorylation of Dok-3 and inhibition of Ca2+ mobilization by Dok-
3  (Stork, 2006). Mutation of this residue also abrogates binding to SHIP (Figure 7, 
lanes 13 and 14). Y140 of Dok-3 is dispensable for both the function and binding to 
SHIP. Y307 of Dok-3 has been shown to be essential for binding to C-terminal Src 
kinase (CSK) (Robson et al., 2004). Mutation of Y307 does not impede Dok-3-mediated 
Figure 7: Dok-3 binds to Grb2 via Y331 and to SHIP via its PTB domain.. 
Wild-type and DT40 variants described in Figure 6 were left untreated (−) or 
BCR-activated (+) and lysates were subjected to anti-HA immunoprecipitation. 
Expression and tyrosine phosphorylation of Dok-3 proteins, as well as their 
association to Grb2 and SHIP, were detected by sequential immunoblotting with 
antibodies to HA, pTyr, Grb2 and SHIP (upper to lower panels, respectively). 
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inhibition of Ca2+ mobilization (Figure 7C). This suggests that the interaction of CSK 
and Dok-3 is also dispensable for Dok-3 function. 
To further analyze if Dok-3 can function independently of SHIP, a dominant-negative 
mutant of Dok-3 was expressed in SHIP-deficient DT40 cells. The Dok-3 mutant 
harboring a Y331F mutation is unable to bind to Grb2 and to inhibit Ca2+ flux. 
Expression of this mutant induces increased Ca2+ mobilization in DT40 wild-type cells, 
probably by competing with endogenous Dok-3 (Figure 8). Similarly, expression of this 
mutant also induces increase in Ca2+ mobilization in DT40 cells deficient for SHIP, 
which means that the endogenous Dok-3 inhibits Ca2+ mobilization in the absence of 
SHIP. This finding further supports the notion that the negative role of Dok-3 in BCR 
signaling is independent of SHIP.      
 
 
 
 
 
 
Figure 8: Dominant-negative mutant of Dok-3 acts in the absence of SHIP. 
BCR-induced Ca2+ fluxes were analyzed as described in the legend to Figure 3 
in SHIP-deficient DT40 cells (ship−/−, brown line) and ship−/− transfectants 
expressing a Dok-3 Y331F variant that counteracts Ca2+ inhibition by 
endogenous wild-type Dok-3 (orange line). As control, parental DT40 cells, 
which are positive for endogenous SHIP and Dok-3 (black line), and the Dok-3 
Y331F transfectants (gray) were analyzed in parallel, demonstrating the 
dominant-negative function of Dok-3 Y331F. 
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5.4 Dok-3 does not influence SHIP and CSK activity 
As described in the former section, mutational analysis of Dok-3 has revealed that Dok-
3 can function independent of SHIP and CSK in DT40 cells. To test, whether Dok-3 
influences the properties of the two proteins, their activity was assayed in Dok-3-
deficient cells. 
As CSK phosphorylates Src-kinases at their C-terminal inhibitory tyrosine and Lyn is 
the only Src-kinase expressed in DT40 cells, the phosphorylation state of both the 
activatory tyrosine (Y416 of human Lyn) and the inhibitory tyrosine (Y507 of human 
Lyn) was determined using antibodies recognizing these two sites, only when 
phosphorylated. No differences in phosphorylation status of Lyn at any of the two sites 
Figure 9: Lyn and SHIP activation is intact in the absence of Dok-3 expression. 
Wild-type DT40 cells (lanes 1-4), dok-3-/- mutants (lanes 5-8) and their 
reconstituted transfectants expressing HA-tagged Dok-3 (lanes 9-12) were left 
untreated (0) or stimulated through their BCR for the indicated times (min). 
Cleared cellular lysates (CCL) were analyzed by immunoblotting with site-specific 
anti-pTyr antibodies to the activating auto-phosphorylation site of Lyn (Y416) 
(upper panel) and the inhibitory pTyr residue 507 (second panel), which is the 
direct substrate of Csk. 
To tyrosine-phophorylated SHIP (Y1020), serine phosphorylated Akt (S473) and 
total Akt (third, fourth and lower panel, respectively). Relative molecular masses 
of marker proteins are indicated on the left in kDa. As the presence or absence of 
Dok-3 expression causes little or no differences in the phosphorylation status of 
the investigated enzymes and/or their downstream effectors, neither SHIP nor Csk 
appear to be a major target of Dok-3. 
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can be observed in Dok-3-deficient cells in response to BCR stimulation (lanes 5-8), 
compared to wild-type parental cells (lanes 1-4) or Dok-3-reconstituted transfectants 
(lanes 9-12) (Figure 9, first and second panel). This again shows no involvement of 
CSK in Dok-3 function downstream of the BCR.   
The phosphorylation of SHIP in response to BCR stimulation was determined by 
Western blot analysis using an antibody recognizing SHIP only when phosphorylated at 
Y1020 (of human SHIP). This tyrosine residue has previously been shown to be 
important for SHIP-mediated inhibition of signaling (Sattler et al., 2001). As shown in 
Figure 9 (middle panel), BCR-induced phosphorylation of SHIP at Y1020 is not altered 
in Dok-3-deficient cells (lanes 5-8) compared to wild-type parental cells (lanes 1-4) or 
Dok-3-reconstituted transfectants (lanes 9-12). Further, phosphorylation of Akt (also 
called PKB) at S473, which depends on the presence of the PI3K product PI(3,4,5)P3 
and therefore is inhibited by SHIP (Aman et al., 1998), is hardly altered (Figure 9, 
Figure 10: Grb2-deficiency leads to reduced SHIP activation  
DT40 grb2-/- mutants were transfected with wild-type Grb2 (lanes1-4)  or empty 
vector (5-8) were left untreated (0) or stimulated through their BCR for the 
indicated times (min). Cleared cellular lysates (CCL) were analyzed by 
immunoblotting with anti-pTyr antibodies to tyrosine-phophorylated SHIP 
(Y1020), serinephosphorylated Akt (S473) and total SHIP and Akt (first, third, 
second and fourth panel, respectively). the activating auto-phosphorylation site of 
Lyn (Y416) (second lowest panel) and the inhibitory pTyr residue 507 (lowest 
panel), which is the direct substrate of Csk. Relative molecular masses of marker 
proteins are indicated on the left in kDa.  
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second lowest panel). Together, this indicates that SHIP is not the target of Dok-3-
mediated inhibition.  
In contrast, phosphorylation of SHIP at Y1020 is reduced in grb2-/- DT40 cells in 
response to BCR ligation (Figure 10, first panel, lanes 5-8) compared to Grb2-
reconstituted transfectants (lanes 1-4). Consequently, phosphorylation of Akt at S473 is 
enhanced in the absence of Grb2 (third panel). This suggests that Grb2 enhances SHIP 
activation and thus inhibits BCR signaling also by additional Dok-3-independent 
mechanisms. The phosphorylation state of Lyn at both activatory and inhibitory tyrosine 
residues is not altered in Grb2-deficient cells (Figure 10, second lowest and lowest 
panel, respectively). Collectively, the data show that Grb2 and Dok-3 constitute a 
signaling module that inhibits PLC-γ2 activation and subsequent Ca2+ mobilization by a 
SHIP and CSK-independent mechanism, while Grb2 seems to have additional Dok-3-
independent functions.  
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5.5 Dok-3 tyrosine phosphorylation is enhanced by FcγRIIb coligation 
As described in the previous section, the inhibitory function of Dok-3 seems to be 
independent of SHIP. Yet, the binding of Dok-3 to SHIP has previously been shown in 
mouse B cells (Robson et al., 2004) and could also be shown in the DT40 system 
(Figure 7). If the interaction is of functional significance, SHIP might rather be 
important for Dok-3 activation than vice versa. SHIP is only weakly phosphorylated in 
B cells stimulated via the BCR. Conversely, co-ligation of the inhibitory co-receptor 
FcγRIIb with the BCR, leads to recruitment of SHIP to FcγRIIb and subsequent strong 
phosphorylation of SHIP by Lyn. As the PTB domain of Dok-3 is required for its 
binding to SHIP, strong phosphorylation of SHIP could lead to recruitment of Dok-3 to 
SHIP in the proximity of Lyn, leading to efficient phosphorylation.  
To test this hypothesis, B cell lines of murine origin were used, since no gene 
homologous to fcgr2b is known in chicken and thus in the DT40 cell line. First, to test 
whether Grb2 is also required for Dok-3 phosphorylation in B cells of murine origin, 
Bal17.TR cells were used. This cells line is derived from Bal17 cells, which were 
subcloned and screened for a Grb2-deficient clone (Harmer and DeFranco, 1999). Re-
expression of Grb2 in this clone indeed enhances Dok-3 tyrosine phosphorylation in 
response to BCR ligation, indicating an evolutionary conserved dependence on Grb2 
expression (Figure 11, compare lanes 2 and 4). To test the effect of FcγRIIb on Dok-3 
phosphorylation, FcγRIIb was co-crosslinked to the BCR by using complete rabbit IgG 
raised against the BCR. Note, that for stimulation of the BCR only, F(ab)2 fragments of 
the same antibody were used. The phosphorylation of Dok-3 is drastically increased by 
co-ligating FcγRIIb to the BCR (Figure 11, lanes 6 and 7).  
The effect of FcγRIIb co-ligation with the BCR on Dok-3 phosphorylation was 
confirmed using another mouse B cell line, WEHI-231 (Figure 12A, lanes 4-6). 
Interestingly, FcγRIIb co-ligation has previously been shown to induce phosphorylation 
of SHC and the Dok-family member Dok-1 and their binding to SHIP (Ott et al., 2002; 
Tridandapani et al., 1997). The enhanced phosphorylation of the former adaptor 
proteins could be recapitulated in WEHI-231 cells. The association of Dok-3 and SHC 
with SHIP was hardly altered in response to FcγRIIb co-ligation in WEHI231 cells 
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(Figure 12A, second panel). In immunoprecipitates of Dok-1, SHIP could not be 
detected, though, which might just be due to the poor quality of the anti-Dok-1 
antibody.  
To asses, whether SHIP forms a single complex with all three adaptor proteins or three 
individual complexes the immunoprecipitates of the adaptor proteins were also probed 
with antibodies to the respective others (Figure 12A, lower panels). Due to the reactivity 
of the secondary antibodies with the rabbit antibodies used for immunoprecipitating 
SHC and for co-ligating FcγRIIb this could not be shown, though. Only in Dok-3 
immunoprecipitates, Dok-1 could be detected. As Dok-1 immunoprecipitation was 
inefficient with the used antibody, this could not be confirmed by detecting Dok-3 in 
anti-Dok-1 immunoprecipitates, though. This leaves the composition of the SHIP 
containing complexes undefined.  
To asses that the effect on Dok-3 phosphorylation is indeed due to co-ligation of 
FcγRIIb by the whole anti-IgM antibody, FcγRIIb was blocked by using an anti-FcgRII 
antibody. As shown in Figure 12B, preincubation of WEHI-231 B cells with FcγRII 
blocking antibody can reverse anti-IgM induced phosphorylation of Dok-3. 
Figure 11 Dok-3 phosphorylation in mouse B cells is enhanced by Grb2 
expression and FcγRIIb co-crosslinking 
The Grb2-deficient mouse B  cell line Bal17.TR, retrovirally reconstituted with 
wild-type Grb2 (lanes 1-2,6) or vector (lanes 3-4,7), was left untreated (0), 
stimulated through their BCRs using F(ab)2 fragments (+), or stimulated with co-
ligation of FcgRIIb using whole IgG antibodies.. Lysates were subjected to anti-
Dok-3 immunopurification and proteins obtained were analyzed by anti-pTyr and 
anti-Dok-3 immunoblotting (upper and lower panels, respectively). 
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Figure 12:.Dok-3 phosphorylation is enhanced by FcgRIIb co-ligation in the B 
cell line WEHI-231. 
(A) WEHI-231 cells were left untreated (-), stimulated through their BCRs using 
F(ab)2 fragments, or stimulated with co-ligation of FcγRIIb using whole IgG 
antibodies, as indicated. Cleared cellular lysates (CCLs) were subjected to anti-
Dok-3, anti-Dok-1 or anti-SHC immunoprecipitation and proteins obtained were 
analyzed by anti-pTyr, anti SHIP, anti-Dok-1, anti-Dok-3, anti-SHC and anti-
Grb2 immunoblotting (from top to bottom). As whole IgG for coligation of BCR 
and FcgRIIb and the SHC antibody were derived from rabbit, crossreaction is 
observed in immunoblots against Dok-1, Dok-3 and SHC.  
(B) WEHI-231 cells were left untreated (-) or preincubated with a blocking anti-
mouse CD32 antibody and subsequently stimulated by anti-BCR whole IgG 
antibody, to co-crosslink BCR and FcγRIIb .CCLs were subjected to anti-Dok-3 or 
anti-SHC immunoprecipitation and proteins obtained were analyzed by anti-pTyr 
and anti-Dok-3 immunoblotting.  
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5.6 Dok-3 binds to phospho-tyrosine 1020 in SHIP 
As shown in Figure 7, a Dok-3 mutant harboring an inactivated PTB domain does not 
associate with SHIP. This suggests that the Dok-3 PTB domain binds to a 
phosphorylated tyrosine motif in SHIP. Two PTB domain-binding motifs in SHIP, 
carrying the consensus binding sequence N-P-x-Y (x stands for any amino acid) have 
been described and both have been shown to bind the PTB domain of SHC (Lamkin et 
al., 1997). To elucidate, if Dok-3 binds to the very same motifs, SHIP mutants were 
generated. The mutants of the PTB binding sites (Y917F and Y1020F) were expressed in 
SHIP-deficient DT40 cells, which had been transfected with the cDNA of human 
FcγRIIb, as DT40 cells do not seem to express an Fc receptor. Upon stimulation via the 
BCR alone or together with FcγRIIb, the ability of Dok-3 and SHC to associate with 
SHIP was assessed by co-immunoprecipitation. As shown in Figure 14A, wild type 
SHIP was co-immunoprecipitated with Dok-3. The interaction was increased by 
stimulation by the BCR and even stronger after FcγRIIb co-ligation. Mutation of Y917 
led to a slightly reduced association of SHIP with Dok-3, but mutation of Y1020 
completely abolished binding to Dok-3. This indicates that Dok-3 exclusively binds to 
the motif containing phospho-Y1020 in SHIP. Contrary to Dok-3, SHC binding to SHIP 
was only abolished, if both tyrosine motifs are mutated (Figure 13B). Interestingly, 
binding of both Dok-3 and SHC to Grb2 is augmented in this cell system upon FcγRIIb 
co-crosslinking. This seems to correlate with the former´s ability to bind to SHIP, 
indicating that Dok-3 may form a similar ternary complex with Grb2 and SHIP, as 
previously described for SHC (Harmer and DeFranco, 1999).  
To test, if the interaction of Dok-3 with Y1020 of SHIP is mediated by its PTB domain, 
the recombinant PTB domain of Dok-3 was used to affinity purify SHIP from the same 
cells as used in Figure 14. To achieve full phosphorylation of the tyrosines in SHIP, 
cells were treated with the phosphatase inhibitor pervanadate. As shown in Figure 14, 
the PTB domain co-purified SHIP from pervanadate treated cells, while the same PTB 
domain rendered inactive by point mutation (R297A) did not, showing that the PTB 
domain is sufficient for interaction. The intact PTB domain could co-purify SHIP 
harboring a mutation at Y917 but not at Y1020, demonstrating the interaction to occur 
at this tyrosine motif. Interestingly, a mutant of SHIP harboring a deletion in the 
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catalytic center could not be co-purified, although Y1020 is strongly phosphorylated. 
This mutant did also not show enhanced interaction with Dok-3 in cells stimulated by 
co-ligation of FcγRIIb as shown in Figure 13. This implicates that the deletion alters the 
Figure 13: Y1020 in SHIP is essential for Dok-3 binding.
(A) SHIP-deficient DT40 cells, stably expressing human FcgRIIb, were 
retrovirally reconstituted with wild-type SHIP or mutants carrying Y to F 
substitutions at Y917, Y1020 or both (YYFF) and a mutant carrying an eight 
amino acid deletion in the catalytic domain (ΔIPase). Similar expression of 
the mutants was confirmed by Western blot analysis (data not shown). Variant 
cells were left untreated (-), stimulated through their BCRs by M4, or 
stimulated with co-ligation of FcγRIIb by addition of  anti-M4 rabbit IgGs, as 
indicated. Cleared cellular lysates (CCLs) were subjected to anti-Dok-3 
immunoprecipitation and proteins obtained were analyzed by anti-SHIP, anti-
Dok-3, anti-Grb2 and anti-pTyr immunoblotting (from top to bottom). 
(B) Lysates described in (A) were subjected to anti-SHC  immunoprecipitation 
and proteins obtained were analyzed by anti-SHIP, anti-SHC, anti-Grb2 and 
anti-pTyr immunoblotting (from top to bottom). 
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conformation of SHIP as such that it does not bind to Dok-3 anymore. Binding to SHC 
is still inducible, probably via Y917. Note, that co-purification of the SHIP mutants is 
done using cell lysates containing native protein, while the phosphospecific antibody, 
recognizing Y1020 was used in Western blot analysis and thus using denatured protein.  
Together, these data show that only phospho-Y1020 of SHIP is required for Dok-3 
binding, while SHC can bind to both phospho-Y917 and phospho-Y1020. The PTB 
domains of SHC and Dok-3 thus seem to have partially overlapping binding sites. This 
implicates that they could either compete for binding or cooperate in binding as SHC 
could still bind to Y917. As co-immunoprecipitation of Dok-3 and SHC did not 
succeed, the phosphorylation of SHC in Dok-3-deficient cells was analyzed. The 
binding of SHC to SHIP is mandatory for its phosphorylation upon BCR stimulation 
(Ingham et al., 1999). As shown in Figure 15, phosphorylation of SHC is enhanced in 
the absence of Dok-3 expression. This argues rather for competition between Dok-3 and 
SHC to bind to SHIP and to be recruited to SHIP-bound Lyn. Further, Grb2 expression 
Figure 14:PTB domain of Dok-3 binds exclusively to Y1020 of SHIP. 
Variants of SHIP-deficient DT40 cells, as described in Figure 13, were left 
untreated or were treated with pervanadate (+) to obtain maximum 
phosphorylation. Lysates were subjected to affinity purification using immobilized, 
recombinant PTB domain of Dok-3 (GST-Dok-3 PTB) or a phosphotyrosine 
binding inactive mutant (GST-Dok-3 PTB R297A). Affinity purified proteins were 
analyzed by anti-SHIP, anti-pTyr and anti-Grb2 immunoblotting. Efficient 
pervanadate induced phosphorylation of SHIP was confirmed by analyzing CCLs 
by anti phospho-SHIP immunoblotting.  
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is required for SHC phosphorylation (Figure 15 B). As both Dok-3 and SHC are 
phosphorylated only in the presence of Grb2, they might not only compete for SHIP but 
also Grb2 binding. The complex interplay between SHIP, Grb2, SHC and Dok-3 has 
thus to be investigated in more detail.   
 
 
 
 
 
Figure 15: Increased SHC phosphorylation in Dok-3-deficient cells.  
(A) Wild-type DT40 cells (lanes 1-2), dok-3-/- mutants (lanes 3-4) and their 
reconstituted transfectants expressing HA-tagged Dok-3 (lanes 5-6) were left untreated 
(0) or stimulated through their BCR for 3min (+). Cleared cellular lysates (CCLs) were 
subjected to anti-SHC immunoprecipitation and proteins obtained were analyzed by 
anti-pTyr and anti-SHC immunoblotting (top block and lower block,respectively). 
(B) Wild-type DT40 cells and mutants deficient for Grb2 were treated as described in 
(A) 
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6 Discussion 
B lymphocyte development, survival and activation rely on signaling via the BCR. The 
outcome of signaling is regulated by constitutive or inducible positive and negative 
signaling elements. In this thesis one negative signaling module comprised of Grb2 and 
Dok-3 was shown to act constitutively and also inducibly after FcγRIIb co-crosslinking. 
FcγRIIb signaling has been shown to be critical for the establishment of peripheral 
tolerance (Takai et al., 1996). Apart from the recruitment and activation of the lipid 
phosphatase SHIP, downstream signaling events are only weakly characterized. The 
question remains, whether or how this receptor affects other negative or positive 
signaling modules.   
6.1 The Dok-3/Grb2 module inhibits IP3-mediated ER Ca2+ store 
depletion  
Crosslinking of the BCR by multivalent or membrane-bound antigens leads to a 
transient or sustained rise in cytosolic Ca2+ concentration. BCR-induced Ca2+ 
mobilization occurs in two phases. In the first phase, the binding of IP3 to its receptors 
in the ER membrane results in release of Ca2+ from ER stores. The depletion of the ER 
Ca2+ stores leads to the second phase of sustained influx of extracellular Ca2+ through 
plasma membrane channels. 
The rise of the cytosolic Ca2+ concentration in BCR-stimulated cells can mainly be 
inhibited by three different mechanisms: First, inhibition of Ca2+ release from the ER, 
which also reduces subsequent store-operated Ca2+ entry. Second, the extrusion of Ca2+ 
from the cytosol to the extracellular space, which results in reduced cytoplasmic Ca2+ 
concentrations in both phases. Third, the inhibition of Ca2+ entry through plasma 
membrane Ca2+ channels. 
During my work Björn Stork could show that the adaptor protein Dok-3 inhibits the rise 
in cytosolic Ca2+ concentration in both phases in response to BCR stimulation 
employing dok-3-/- DT40 B cells (Stork, 2006). However, for unknown reasons, 
overexpression of mouse Dok-3 does not inhibit Ca2+ mobilization (Robson et al., 
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2004). Grb2 has previously been shown to inhibit Ca2+ mobilization in response to BCR 
ligation. As Grb2-deficient DT40 cells show especially stronger Ca2+ entry than their 
wild-type counterparts, the authors suggested a role in regulating Ca2+ entry across the 
plasma membrane (Stork et al., 2004). 
This thesis now clearly establishes that both Grb2 and Dok-3 solely act on the first 
mechanism, inhibition of Ca2+ release from the ER Ca2+ stores. First, the amount of Ca2+ 
remaining in the ER after the signal terminated was significantly decreased in DT40 
cells deficient for Grb2 or Dok-3 as compared to their wild type counterparts. Per se, 
this stronger degree of store depletion leads to increased store-operated Ca2+ entry 
(Engelke et al., 2007). If the efflux of Ca2+ from the cytoplasm to the extracellular space 
was compromised in the mutant cell lines, similar or even greater amounts of Ca2+ 
would have been expected to remain in the ER Ca2+ stores as compared to wild type 
counterparts. Second, the Ca2+ entry is not influenced by Grb2 or Dok-3 expression, 
when the ER is artificially depleted by the pharmacological agent Thapsigargin. Thus, 
CRAC channels seem not to be directly influenced by Dok-3 and Grb2. Very similar 
experiments have previously been described for SHIP-deficient cells, establishing 
SHIP´s role in inhibiting release of Ca2+ from internal stores only (Hashimoto et al., 
1999).  
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6.2 Grb2 and Dok-3 inhibit Btk-mediated PLC-γ2 activation 
As the release of Ca2+ from the ER is mediated by IP3 binding to its receptors, it was 
consequential to assay IP3 levels in both activated Grb2 and Dok-3-deficient cells. In 
both mutant cell lines the BCR-induced rise in IP3 levels was much stronger than in 
their wild-type counterparts. This could either be due to higher activity of PLC-γ2 or 
reduced IP3 degradation. The actual activity of PLC-γ2 was not tested in vitro, but 
phosphorylation at a tyrosine critical for activation of PLC-γ2 is strongly increased in 
Grb2 and Dok-3-deficient DT40 cells. This Y759 (of human PLC-γ2) is located in the 
linker region of PLC-γ2 and is phosphorylated by Btk after BCR stimulation. 
Phosphorylation by Btk at Y759 and Y753 has been shown to correlate with PLC-γ2 
activation (Humphries et al., 2004; Kim et al., 2004) 
In Grb2-deficient cells, phosphorylation of PLC-γ2 at Y759 could not be assayed due to 
a low signal to noise ratio and total tyrosine phosphorylation of PLC-γ2 was not 
changed as detected by a general anti-phosphotyrosine antibody. To circumvent this 
partly contradicting finding, Btk was overexpressed in Grb2-deficient cells. This 
consequently increased total tyrosine phosphorylation of PLC-γ2 and also 
phosphorylation at  Y759. In cells overexpressing Btk, the influence of Grb2 on PLC-γ2 
phosphorylation could be clearly shown. Not only phosphorylation on Y759, but even 
total tyrosine phosphorylation of PLC-γ2 is inhibited by Grb2 in cells overexpressing 
Btk. This shows on the one hand, that Btk-mediated phosphorylation of PLC-γ2 is 
Figure 16: Inhibition of BCR-induced Ca2+ signaling by the Dok-3/Grb2 module. 
 The Dok-3 adaptor protein is tehthered at the inner side of the plasma membrane by 
virtue of its PH domain. BCR-stimulation induces phosphorylation of Dok-3 and 
interaction with Grb2. This leads to reduced Btk-mediated activation of PLC-γ2 by 
interfering with the proper formation of the SLP-65-assembled Ca2+ initiatiation 
complex and/or inhibiting the enzymatic activity of Btk. Positive and negative 
regulators of Ca2+ mobilization are illustrated by open and filled boxes, resectively. 
The BCR complex is depicted in grey. 
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inhibited by Grb2. On the other hand, Btk-independent phosphorylation at other sites of 
PLC-γ2 seems not to be influenced by Grb2.  
The total tyrosine phosphorylation of PLC-γ2 in response to BCR ligation is increased 
in Dok-3-deficient DT40 cells, which is not the case in Grb2-deficient DT40 cells. Also, 
IP3 production and Ca2+ mobilization is stronger in Dok-3-deficient DT40 cells, as 
compared to Grb2-deficient DT40 cells. Thus, the inhibitory function of Dok-3 seems to 
be stronger than that of Grb2. This notion is surprising as Grb2 is also required for 
efficient phosphorylation of SHIP, a well characterized inhibitor of Ca2+ mobilization in 
B cells. This discrepancy is either due to residual Dok-3 activity in the absence of Grb2 
or more likely, additional positive regulatory functions of Grb2 in BCR signaling. 
6.3 Dok-3 acts independently of SHIP 
Data presented in this thesis show that both Dok-3 and Grb2 associate with SHIP in 
DT40 B cells stimulated via the BCR (Figure 7), which has been shown in mouse B 
cells before (Harmer and DeFranco, 1999; Lemay et al., 2000). Surprisingly though, 
data presented in this thesis implicate Dok-3 to act independently of SHIP. First, a SHIP 
binding-deficient mutant of Dok-3, in which the PTB domain was inactivated, showed 
similar inhibition of Ca2+-flux as compared to wild-type Dok-3. Second, a mutant 
version of Dok-3, in which the binding site of Grb2 was mutated, acted as a dominant-
negative mutant in both wild-type and SHIP-deficient DT40 cells. Third, 
phosphorylation of SHIP was only slightly reduced in Dok-3-deficient DT40 cells. And 
last, phosphorylation of Akt, which is inhibited by SHIP (Aman et al., 1998), was not 
altered in Dok-3-deficient DT40 cells.  
This does not mean that the interaction between Dok-3 and SHIP is functionally 
irrelevant. In mouse B cells, showing less Dok-3 phosphorylation upon BCR 
stimulation, Dok-3 phosphorylation is enhanced by FcγRIIb co-ligation. This is most 
likely due to PTB domain-mediated recruitment of Dok-3 to phosphorylated SHIP. 
SHIP is recruited directly via its SH2 domain to FcγRIIb and co-localizes with Lyn 
under negative signaling conditions (Bewarder et al., 1996; Tridandapani et al., 1997), 
and thus could recruit Dok-3 into the proximity of Lyn, supporting its phosphorylation.  
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Thus, there seem to be at least 2 ways to recruit Dok-3 into the proximity of Lyn at the 
plasma membrane. In DT40 cells, a SHIP-independent mechanism leads to strong Dok-
3 phosphorylation. In cells originating from other developmental stages or species, Dok-
3 activation might require the second pathway via SHIP. Interestingly, Dok-3 is 
constitutively associated with the plasma membrane in DT40 cells (Goldbeck, 2007). In 
mouse fibroblasts Dok-3 is localized in the cytoplasm (Cong et al., 1999). The 
constitutive membrane anchoring of Dok-3 in DT40 cells might make SHIP-dependent 
membrane recruitment unnecessary. Further work will elucidate the mechanism of Dok-
3 membrane/lipid raft recruitment in B cells of different species or developmental 
stages. 
A very recent publication supports a function of Dok-3 in primary mouse B cells similar 
to that observed in DT40 B cells (Ng et al., 2007). B cells isolated from dok3-/- mice 
showed similar hyper responsiveness to BCR stimulation as the dok3-/- DT40 cells 
analyzed in this thesis. Interestingly, in B cells of the mutant mice, SHIP 
phosphorylation at Y1020 is severely compromised as compared to wild-type cells. This 
is contradictory to the data provided in this thesis and may emphasize the above notion 
that activation and maybe also function of Dok-3 is different in cells of different species 
and developmental stage. Still, the data presented in this thesis strongly suggest an 
additional mode of function of Dok-3 independent of SHIP.  
The DT40 system employed in this thesis is not per se less meaningful as compared to 
gene-targeted mice. DT40 is a transformed cell line that it is less phylogenetically 
related to the human system than are mice. The DT40 system is advantageous in 2 
respects: First, conventional gene targeting strategies in mice can lead to developmental 
differences, especially in B and T cells. Lymphocyte development depends on signals 
emanating from their immunoreceptors (preBCR/preTCR for development and 
BCR/TCR for positive and negative selection). Thus, differences in signal transduction 
of mature lymphocytes can just arise from distinct selection of progenitor cells. Second, 
reconstitution experiments proving the specificity of the results are harder to perform in 
primary cells. Thus, the DT40 system is powerful complementary system. 
In contrast to Dok-3, Grb2 seems to have a stronger impact on SHIP phosphorylation 
and function (Figure 9), which has not been investigated in mice, as grb2-/- mice are not 
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viable (Cheng et al., 1998). Although Grb2 is required for Dok-3 function, as shown in 
this and previous work (Goldbeck, 2007; Stork, 2006), it is likely that Grb2 has further 
effects on BCR signaling. First, Grb2 is not only required for BCR induced 
phosphorylation of Dok-3, but also of SHIP and SHC (this work and (Harmer and 
DeFranco, 1999)). This could mean that Grb2 might have a more general role in 
recruiting target proteins to Lyn. Second, Grb2 has been shown to interact with a 
plethora of proteins involved in BCR signaling, e.g. SLP-65, CD2AP, HPK-1, Cbl, 
SHP-1 and SHP-2 just to name a few. The functional spectrum of Grb2 could even 
broaden, as it has been shown to be phosphorylated at two tyrosine residues in its C-
terminal SH3 domain downstream of the of the epidermal growth factor receptor (Olsen 
et al., 2006). Last, the phenotype of Grb2-deficient DT40 cells is less severe in terms of 
enhanced Ca2+-flux and IP3 production as compared to Dok-3 or SHIP-deficient cells. 
This argues for additional positive roles of Grb2 in BCR signaling, which are absent in 
grb2-/- cells as well. Interestingly, such a role has been described in other receptor 
systems. Recently, Grb2 has been shown to be essential for recruitment of the p85 
subunit of PI3K to DAP10 and subsequent Ca2+ flux (Upshaw et al., 2006). This 
NKG2D-associated co-receptor has a similar Grb2-binding site as the co stimulatory co-
receptor of T cells, CD28, which also binds to Grb2 (Kim et al., 1998). Also, binding to 
LAT or the closely related NTAL has been shown to positively regulate signaling 
(Houtman et al., 2006; Stork et al., 2004). These data strongly suggest a pleiotropic 
effect of Grb2 also in B cell signaling with the cellular context determining the net 
outcome, positive or negative.  
6.4 SHIP-SHC-Dok complexes 
The interaction of SHIP with SHC has been investigated in detail (Harmer and 
DeFranco, 1999). SHC binds via its PTB domain to phosphorylated Y917 or Y1020 of 
SHIP. This interaction in not sufficient to induce stable complex formation, though. 
Grb2 stabilizes the interaction by binding to both SHC and SHIP, which leads to 
formation of a ternary complex. Grb2 binds to a phosphorylated tyrosine in SHC via its 
SH2 domain and to SHIP via its C-terminal SH3 domain (Figure 17A). Similar to SHC, 
also Dok-3 binds via its PTB domain to SHIP, albeit exclusively to Y1020. Further, 
Grb2 binds to Dok-3 Y331 via its SH2 domain and could thus also stabilize the Dok-
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3/SHIP interaction by simultaneously binding to SHIP via its SH3 domain (Figure 17B). 
Harmer et al. showed that supplementing lysates of Grb2-deficient B cells with 
recombinant Grb2 enhances SHC/SHIP interaction, proving that Grb2 binds to both 
proteins simultaneously. This kind of experiment is planned for the Dok-3/SHIP 
interaction, and will show whether the herein proposed binding model is true.  
As Dok-3 and SHC seem to bind to SHIP in a similar fashion, it is feasible to propose a 
model in which SHIP can form two distinct ternary complexes, either with Grb2 and 
SHC or with Grb2 and Dok-3, which is coined herein as the “Alternative Binding 
Model”. This model would exclude a simultaneous binding of SHIP to both SHC and 
Dok-3, and thus a complex containing both SHC and Dok-3. Co-immunoprecipitation 
studies during this thesis could not show an interaction of SHC and Dok-3, but a 
negative result is of course not a proof, that this interaction does not occur. To prove the 
model, it has to be shown, that SHC and Dok-3 compete for binding to SHIP, rather 
than cooperate in binding to SHIP. This is supported by the fact, that SHC 
phosphorylation, which requires binding to SHIP (Ingham et al., 1999), is increased in 
Dok-3-deficient DT40 cells, albeit mainly the longer isoform (p52) (Figure 15). To 
show competitive binding, recombinant SHC or Dok-3 could be added to lysates of 
stimulated B cells. According to the model, the association of the respective other 
protein with SHIP should then decrease. Using the two isoforms of SHC could then also 
elucidate a potential distinct mode of action of those. As phosphorylated recombinant 
Figure 17: Alternative binding model. A) SHC binds to SHIP Y917 or Y1020 via its PTB domain and 
Grb2 stabilizes the interaction by binding to SHC via its SH2 domain and to SHIP via its C-terminal 
SH3 domain; adapted from (Harmer and DeFranco, 1999). B) Dok-3 binds to SHIP Y1020 via its 
PTB domain. Grb2 binds to Dok-3 Y331 via its SH2 domain and presumably at the same time to 
SHIP via its C-terminal SH3 domain, which leads to a ternary comlex, similar to complex formed by 
SHC.  
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SHC or Dok-3 is required, purification strategies for tagged proteins from DT40 are 
currently being established. 
6.5 Role of Dok-3 in FcγRIIb signaling 
The data provided in this thesis indicate that  SHIP associates with Dok-3 after FcγRIIb 
coligation and previous publications indicate that SHIP associates also with Grb2, SHC, 
and Dok-1 after FcγRIIb coligation (Harmer and DeFranco, 1999; Ott et al., 2002; 
Tamir et al., 2000). Except for Dok-1, which inhibits ERK activation, no functional 
significance of any of these interactions for FcγRIIb signaling has been shown. In 
murine FcγRIIb, a Grb2-binding site is present, which enhances SHIP recruitment, but 
this site is not conserved in the human orthologue (Isnardi et al., 2004). Binding of SHC 
and Grb2 to SHIP has been suggested to inhibit Ras activation by sequestering the 
former from SOS, but SOS has later been shown to be dispensable for Ras activation in 
DT40 B cells (Oh-hora et al., 2003; Tridandapani et al., 1998). In the DT40 system 
Grb2, Dok-3 and SHC are not essential for inhibition of Ca2+ mobilization by FcγRIIb 
(data not shown). As Dok-3 is clearly a strong inhibitor of Ca2+ mobilization in response 
to BCR ligation, this seems surprising at first. This can be explained by the already 
strong phosphorylation of Dok-3 after BCR crosslinking only, which is independent of 
SHIP expression (B.Stork, unpublished observation). Co-ligation of FcγRIIb 
consequently does not enhance Dok-3 phosphorylation in this system (data not shown). 
Note that DT40 cells seem not to express an Fc receptor similar to FcγRIIb. This 
implies that DT40 cells or chicken B cells in general have a distinct mode of Dok-3 
activation, making this system unfavorable for investigating its role in FcγRIIb 
signaling. Further, Dok-3 acts on Btk-mediated PLC-γ2 activation, which is the very 
same mechanism by which SHIP inhibits Ca2+ mobilization (Bolland et al., 1998). This 
makes it difficult to distinguish between SHIP and Dok-3 function.  
Dok-3 phosphorylation depends on Grb2 expression, and in DT40 cells Dok-3 is the 
main Grb2-binding protein after BCR stimulation (Goldbeck, 2007). B cells from other 
developmental stages or species express other Grb2-binding proteins, like the 
transmembrane adaptor NTAL. In these cells, Dok-3 has to compete for binding to 
Grb2, which may be one reason for low Dok-3 phosphorylation in mouse B cells. This 
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implies that high expression of NTAL in DT40 cells should lead to decreased BCR-
mediated Dok-3 phosphorylation. It would be interesting to see, whether FcγRIIb co-
ligation would lead to again increased Dok-3 phosphorylation.  
Anyhow, to see whether the adapter proteins recruited to SHIP bring additional 
signaling functions or solely regulate SHIP activity remains to be elucidated. This was 
attempted during this thesis by expressing a catalytically inactive mutant of SHIP, but 
the deletion mutant shown in Figure 13 seems to have a distorted structure and a point 
mutation (D676G) resulted in strongly reduced expression compared to wild-type SHIP. 
Together, these drawbacks make the DT40 system unfavorable for the analysis of 
FcγRIIb signaling. 
Immuncomplexes that do not contain antigen recognized by the BCR can crosslink 
FcγRIIb alone, which induces apotosis. The pathway leading to apoptosis is 
independent of the ITIM and SHIP, but requires activity of members of the Abl family 
of tyrosine kinases (Tzeng et al., 2005). Indeed, SHIP expression even inhibits 
apoptosis induced by FcγRIIb. This led the authors to propose, that the two pathways 
emanating from FcγRIIb block the respective other to fully skew a response to one 
pathway, either recruitment of SHIP or Abl. As Dok-3 inhibits Abl activity (Cong et al., 
1999) it would be feasible to propose, that the Dok-3 function downstream of FcγRIIb 
could be to block the Abl dependent pathway to apoptosis.  
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6.6 Outlook 
It is shown in this thesis that Dok-3 and Grb2 together inhibit Btk-mediated 
phosphorylation of PLC-γ2. As none of the known binding partners of Dok-3 seems to 
be involved in this and Grb2 is also an adaptor protein, another unknown protein seems 
to be required. Attempts to identify proteins interacting with Dok-3 in response to BCR 
stimulation have been undertaken. Tagged Dok-3 was purified from stimulated DT40 
cells but no co-purified interacting partners could be identified yet. In a similar 
approach using a tagged version of SLP-65 several known and unknown binding 
partners of SLP-65 could be identified by mass spectrometry (K. Neumann, T. 
Oellerich, unpublished). Interestingly, also Dok-3 was co-purified with SLP-65. As 
background proteins were subtracted using the recently developed method of stable 
isotope labeling in cell culture (SILAC) (Ong et al., 2002), this strongly suggests Dok-3 
to associate with SLP-65 and thus with the Ca2+ initiation complex. Further experiments 
will show whether the association is direct or via Grb2 and whether this interaction is 
able to perturb the integrity of the Ca2+ initiation complex, which would nicely explain 
the phenotype of the dok3-/- cells.  
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